United States Diagnostic Imaging Market Outlook to 2020 · United States Diagnostic Imaging Market...

United States Diagnostic Imaging Market Outlook to 2020 GDMEMC0016DB / Published March 2014

© GlobalData. This report is a licensed product and is not to be copied,

reproduced, shared or resold in any form

United States Diagnostic Imaging

Market Outlook to 2020

Reference Code: GDMEMC0016DB

Publication Date: March 2014




1 Table of Contents 1 Table of Contents .................................................................................................................................................... 2

1.1 List of Tables .................................................................................................................................................. 37

1.2 List of Figures ................................................................................................................................................. 46

2 Introduction ............................................................................................................................................................ 49

2.1 What Is This Report About? ........................................................................................................................... 49

2.2 Diagnostic Imaging Market Segmentation ..................................................................................................... 49

2.3 Definitions of Markets Covered in the Report ................................................................................................ 51

3 Diagnostic Imaging Market, United States .......................................................................................................... 57

3.1 Diagnostic Imaging Market, United States, Revenue ($m), 2005-2020 ......................................................... 57

3.2 Diagnostic Imaging Market, United States, Revenue Mix ($m), 2012 ........................................................... 59

3.3 Diagnostic Imaging Market, United States, Category Contribution by Revenue ($m), 2012 ......................... 60

3.4 Diagnostic Imaging Market, United States, Category Comparison by Revenue ($m), 2005-2020 ............... 62



3.7 Diagnostic Imaging Market, United States, Volume (Units), 2005-2020 ........................................................ 68



3.10 Diagnostic Imaging Market, United States, Company Share by Revenue ($m), 2011-2012......................... 74

4 Angio Suites Market, United States ..................................................................................................................... 76

4.1 Angio Suites Market, United States, Revenue ($m), 2005-2012 ................................................................... 76

4.2 Angio Suites Market, United States, Revenue ($m), 2012-2020 ................................................................... 77

4.3 Angio Suites Market, United States, Volume (Units), 2005-2012 .................................................................. 78

4.4 Angio Suites Market, United States, Volume (Units), 2012-2020 .................................................................. 79

4.5 Angio Suites Market, United States, Distribution Share by Revenue ($m), 2011-2012 ................................ 80

4.6 Angio Suites Market, United States, Company Share by Revenue ($m), 2011-2012 ................................... 81

5 Bone Densitometers Market, United States ........................................................................................................ 83

5.1 Bone Densitometers Market, United States, Revenue ($m), 2005-2012 ....................................................... 83

5.2 Bone Densitometers Market, United States, Revenue ($m), 2012-2020 ....................................................... 85

5.3 Bone Densitometers Market, United States, Volume (Units), 2005-2012 ...................................................... 86

5.4 Bone Densitometers Market, United States, Volume (Units), 2012-2020 ...................................................... 87

5.5 Bone Densitometers Market, United States, Distribution Share by Revenue ($m), 2011-2012 .................... 88

5.6 Bone Densitometers Market, United States, Company Share by Revenue ($m), 2011-2012....................... 89

6 C-Arms Market, United States .............................................................................................................................. 90

6.1 C-Arms Market, United States, Revenue ($m), 2005-2012 ........................................................................... 90

6.2 C-Arms Market, United States, Revenue ($m), 2012-2020 ........................................................................... 91

6.3 C-Arms Market, United States, Volume (Units), 2005-2012 .......................................................................... 92

6.4 C-Arms Market, United States, Volume (Units), 2012-2020 .......................................................................... 93




6.5 C-Arms Market, United States, Distribution Share by Revenue ($m), 2011-2012 ........................................ 94

6.6 C-Arms Market, United States, Company Share by Revenue ($m), 2011-2012 ........................................... 95

7 Computed Tomography Systems Market, United States .................................................................................. 97

7.1 Computed Tomography Systems Market, United States, Revenue ($m), 2005-2012 .................................. 97

7.2 Computed Tomography Systems Market, United States, Revenue ($m), 2012-2020 .................................. 98

7.3 Computed Tomography Systems Market, United States, Volume (Units), 2005-2012 ................................. 99

7.4 Computed Tomography Systems Market, United States, Volume (Units), 2012-2020 ............................... 100

7.5 Computed Tomography Systems Market, United States, Distribution Share by Revenue ($m), 2011-2012

101

7.6 Computed Tomography Systems Market, United States, Company Share by Revenue ($m), 2011-2012 102

8 Contrast Media Injectors Market, United States ............................................................................................... 104

8.1 Contrast Media Injectors Market, United States, Revenue ($m), 2005-2012 .............................................. 104

8.2 Contrast Media Injectors Market, United States, Revenue ($m), 2012-2020 .............................................. 105

8.3 Contrast Media Injectors Market, United States, Volume (Units), 2005-2012 ............................................. 106

8.4 Contrast Media Injectors Market, United States, Volume (Units), 2012-2020 ............................................. 107

8.5 Contrast Media Injectors Market, United States, Distribution Share by Revenue ($m), 2011-2012............ 108

8.6 Contrast Media Injectors Market, United States, Company Share by Revenue ($m), 2011-2012 .............. 109

9 Mammography Equipment Market, United States ............................................................................................ 110

9.1 Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Revenue

($m), 2005-2012 ....................................................................................................................................................... 110

9.2 Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Revenue

($m), 2012-2020 ....................................................................................................................................................... 112

9.3 Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Volume

(Units), 2005-2012 .................................................................................................................................................... 113

9.4 Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Volume

(Units), 2012-2020 .................................................................................................................................................... 115

9.5 Mammography Equipment Market, United States, Distribution Share by Revenue ($m), 2011-2012 ........ 117

9.6 Mammography Equipment Market, United States, Company Share by Revenue ($m), 2011-2012 ........... 118

10 MRI Systems Market, United States ............................................................................................................... 120

10.1 MRI Systems Market, United States, Revenue ($m), 2005-2012 ................................................................ 120

10.2 MRI Systems Market, United States, Revenue ($m), 2012-2020 ................................................................ 121

10.3 MRI Systems Market, United States, Volume (Units), 2005-2012 ............................................................... 122

10.4 MRI Systems Market, United States, Volume (Units), 2012-2020 ............................................................... 123

10.5 MRI Systems Market, United States, Distribution Share by Revenue ($m), 2011-2012 ............................. 124

10.6 MRI Systems Market, United States, Company Share by Revenue ($m), 2011-2012 ................................ 125

11 Nuclear Imaging Equipment Market, United States ...................................................................................... 127

11.1 Nuclear Imaging Equipment Market, United States, Revenue Mix ($m), 2012 ........................................... 127

11.2 Nuclear Imaging Equipment Market, United States, Segment Contribution (%), 2012 ............................... 128

11.3 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2005-2012 ......................................... 129




11.4 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2012-2020 ......................................... 131

11.5 Nuclear Imaging Equipment Market, United States, Volume (Units), 2005-2012 ........................................ 133

11.6 Nuclear Imaging Equipment Market, United States, Volume (Units), 2012-2020 ........................................ 135

11.7 Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), 2011-2012 ...... 137

11.8 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2011-2012 ......... 138

12 Ultrasound Systems Market, United States ................................................................................................... 140

12.1 Ultrasound Systems Market, United States, Revenue Mix ($m), 2012 ........................................................ 140

12.2 Ultrasound Systems Market, United States, Segment Contribution (%), 2012............................................ 141

12.3 Ultrasound Systems Market, United States, Revenue ($m), 2005-2012 ..................................................... 142

12.4 Ultrasound Systems Market, United States, Revenue ($m), 2012-2020 ..................................................... 144

12.5 Ultrasound Systems Market, United States, Volume (Units), 2005-2012 .................................................... 146

12.6 Ultrasound Systems Market, United States, Volume (Units), 2012-2020 .................................................... 148

12.7 Ultrasound Systems Market, United States, Distribution Share by Revenue ($m), 2011-2012 .................. 150

12.8 Ultrasound Systems Market, United States, Company Share by Revenue ($m), 2011-2012 ..................... 151

13 X-ray Systems Market, United States ............................................................................................................. 153

13.1 X-ray Systems Market, United States, Revenue Mix ($m), 2012 ................................................................ 153

13.2 X-ray Systems Market, United States, Segment Contribution (%), 2012 .................................................... 154

13.3 X-ray Systems Market, United States, Revenue ($m), 2005-2012 .............................................................. 155

13.4 X-ray Systems Market, United States, Revenue ($m), 2012-2020 .............................................................. 157

13.5 X-ray Systems Market, United States, Volume (Units), 2005-2012 ............................................................. 159

13.6 X-ray Systems Market, United States, Volume (Units), 2012-2020 ............................................................. 161

13.7 X-ray Systems Market, United States, Distribution Share by Revenue ($m), 2011-2012 ........................... 163

13.8 X-ray Systems Market, United States, Company Share by Revenue ($m), 2011-2012 .............................. 164

14 Overview of Key Companies in United States, Market ................................................................................. 166

14.1 GE Healthcare .............................................................................................................................................. 166

14.1.1 Company Overview .............................................................................................................................. 166

14.2 Philips Healthcare ........................................................................................................................................ 166


14.3 Siemens Healthcare ..................................................................................................................................... 167


14.4 Toshiba Medical Systems Corporation ........................................................................................................ 167


14.5 Hologic, Inc. .................................................................................................................................................. 167


14.6 Esaote S.p.A. ............................................................................................................................................... 168


14.7 Fujifilm Holdings Corporation ....................................................................................................................... 168





14.8 Hitachi Medical Corporation ......................................................................................................................... 168


15 Diagnostic Imaging Market Pipeline Products .............................................................................................. 170

16 Financial Deals Landscape ............................................................................................................................. 174

16.1 Acquisition .................................................................................................................................................... 174

16.1.1 Accellent To Acquire Lake Region Medical, Manufacturer Of Medical Devices .................................. 174

16.1.2 Medovations Acquires Sandhill Scientific............................................................................................. 176

16.1.3 Globus Medical Acquires Excelsius Surgical, Medical Device Company ............................................ 177

16.1.4 Channel Technologies Acquires H.C. Materials .................................................................................. 178

16.1.5 Thorlabs Acquires CompuCyte, Laser Scanning Cytometry Products Provider .................................. 179

16.1.6 Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics ....................................... 180

16.1.7 Analogic Acquires Remaining Majority Stake In PocketSonics, Ultrasound Technology Company, For

Up To US$14 Million .............................................................................................................................................. 181

16.1.8 BC Technical Acquires C&G Technologies, Computed Tomography Solutions Provider ................... 182

16.1.9 One Call Care Management Rumored To Sell Itself For Up To US$1.5 Billion................................... 183

16.1.10 Techne Completes Acquisition Of Bionostics For US$104 Million ...................................................... 184

16.1.11 Carl Zeiss Completes Acquisition Of Xradia ........................................................................................ 186

16.1.12 BC Technical Acquires Medx, Molecular Imaging Company ............................................................... 188

16.1.13 Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million ........... 189

16.1.14 BC Technical Acquires Nuclear Cardiology Systems, Provider Of Nuclear Medical Services ............ 191

16.1.15 Analytik Jena To Acquire UVP, Digital Imaging Provider ..................................................................... 192

16.1.16 Solta Medical Completes Acquisition Of Sound Surgical For Up To US$40 Million ............................ 194

16.1.17 Samsung Electronics America Acquires NeuroLogica, Medical Imaging Company ............................ 196

16.1.18 Aris Teleradiology Acquires Pediatric Radiology of America ............................................................... 197

16.1.19 GSI Group Acquires NDS Surgical Imaging For US$83 Million ........................................................... 198

16.1.20 RadNet Acquires Lenox Hill Radiology, Provider Of Diagnostic Imaging Services, For US$30 Million

200

16.1.21 Claymount North America Acquires Advanced Instrument Development ........................................... 201

16.1.22 BC Technical Completes Acquisition Of Genesis Medical Imaging ..................................................... 202

16.1.23 Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance

Spectrometer ......................................................................................................................................................... 203

16.1.24 Endeavor Power Acquires Parallax Diagnostics, Bio-Medical Company ............................................ 204

16.1.25 Solanbridge Group Acquires Advanced Medical Sales For US$0.2 Million ......................................... 205

16.1.26 KMH Labs Acquires Westcoast Radiology........................................................................................... 206

16.1.27 Merit Medical Systems Acquires Medigroup, Maker Of Peritoneal Dialysis Catheters ....................... 207

16.1.28 Eczacibasi-Monrol Nukleer Urunler Completes Acquisition Of Capintec, Developer Of Nuclear

Medicine Equipment .............................................................................................................................................. 208

16.1.29 GE Healthcare Acquires U-Systems, Maker Of Breast Ultrasound Systems ...................................... 209

16.1.30 Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes ....................................... 211




16.1.31 Carestream Health Acquires Genesis Digital Imaging ......................................................................... 212

16.1.32 ITW Medical Acquires Coeur, Provider Of Medical Disposables ......................................................... 214

16.1.33 Siemens Healthcare To Acquire Penrith, Maker Of Ultrasound Imaging Systems .............................. 216

16.1.34 Diagnostic Imaging International Completes Acquisition Of Schulkyll Open MRI For US$2.2 Million 217

16.1.35 Accuray Acquires 90% Stake In Morphormics, Developer Of Medical Imaging Software, For US$6

Million 218

16.1.36 InSight Health Services Completes Acquisition Of Center for Diagnostic Imaging For US$91 Million 220

16.1.37 BC Technical Acquires Xpert, Molecular Imaging Service Company .................................................. 222

16.1.38 BC Technical Acquires Consus Medical Imaging, Molecular Imaging Equipment Service Provider ... 223

16.1.39 BC Technical Acquires RA Services, Molecular Imaging Equipment Service Provider ...................... 224

16.1.40 RadNet Acquires West Coast Radiology For US$10 Million ................................................................ 225

16.2 Asset Transactions ....................................................................................................................................... 226

16.2.1 Dilon Technologies Acquires Navigator Gamma Probes From RMD Instruments .............................. 226

16.2.2 Maven Biotechnologies Plans To Sell Label-Free Detection And Imaging Technology ...................... 228

16.2.3 Tristate Imaging Acquires 16 Diagnostic Imaging Centers .................................................................. 229

16.2.4 Novadaq Technologies Acquires Surgical Marker Technology From TauTona .................................. 230

16.2.5 Volcano To Acquire Pioneer Plus Re-Entry Catheter Product Line From Medtronic .......................... 232

16.2.6 Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For US$3 Million

234

16.2.7 GE Healthcare Acquires Transactional Business Of Unisyn Medical Technologies ........................... 236

16.2.8 Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions ......... 238

16.2.9 Threshold Pharma To Acquire Hypoxia PET Imaging Agent 18F-HX4 From Siemens Healthcare .... 240

16.2.10 Northridge Trimodality Imaging Acquires Pre-Clinical Imaging Division Of Gamma Medica For US$2.5

Million 242

16.2.11 Fonar Acquires 14 MRI Scanning Centers For US$34.4 Million .......................................................... 243

16.2.12 Bruker To Acquire Preclinical In-Vivo Imaging Business From Carestream Health ............................ 244

16.2.13 Tranzbyte To Acquire Marketing Rights To MRI Machines In North And South America From Hurricane

Enterprises ............................................................................................................................................................. 246

16.2.14 Acacia Research Acquires Patents For X-Ray Powder Diffraction Technology .................................. 247

16.3 Debt Offerings .............................................................................................................................................. 248

16.3.1 Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million ........................... 248

16.3.2 Idexx Labs Completes Private Placement Of Series B Notes Due 2025 For US$75 Million ............... 250

16.3.3 Idexx Labs Completes Private Placement Of Series A Notes Due 2023 For US$75 Million ............... 251

16.3.4 Johnson & Johnson Prices Public Offering Of Notes Due 2016 For US$400 Million .......................... 252









16.3.10 Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million ........................ 264

16.3.11 Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million ........................ 266

16.3.12 Accuray Completes Private Placement Of Notes Due 2018 For US$100 Million ................................ 268

16.3.13 Computer Vision Systems Labs Announces Private Placement Of Notes For US$20 Million ............ 270

16.3.14 Diagnostic Imaging International Completes Private Placement Of Notes Due 2015 For US$2 Million

271

16.3.15 Roper Industries Completes Public Offering Of Notes Due 2017 For US$400 Million ........................ 272

16.3.16 Roper Industries Completes Public Offering Of Notes Due 2022 For US$500 Million ........................ 274

16.3.17 Imaging3 Completes Private Placement Of Notes For US$0.3 Million ................................................ 276

16.3.18 International Isotopes Completes Private Placement Of 8% Convertible Notes Due 2017 For US$3

Million 277

16.3.19 Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion .......................... 279

16.3.20 Radiation Therapy Services Completes Private Placement Of Notes Due 2017 For US$350 Million 280

16.4 Equity Offerings ............................................................................................................................................ 282

16.4.1 Merit Medical Systems Files Registration Statement For Public Offering Of Securities For US$200

Million 282

16.4.2 MicroVision Files Registration Statement For Public Offering Of Securities For US$25 Million .......... 284

16.4.3 Exosome Sciences Completes Private Placement Shares For US$1.1 Million ................................... 285

16.4.4 Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250

Million 286

16.4.5 Caliber Imaging & Diagnostics Announces Private Placement Of Common Stock ............................. 287

16.4.6 Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million ................. 288

16.4.7 Navidea Biopharma Completes Private Placement Of Units For US$30 Million ................................. 290

16.4.8 FluoroPharma Medical Completes First Tranche Of Private Placement Of Preferred Shares And

Warrants For US$0.7 Million ................................................................................................................................. 292

16.4.9 Enzo Biochem Files Shelf Registration Statement For Public Offering Of Securities For US$50 Million

294

16.4.10 Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million ........................ 295

16.4.11 Advanced Medical Isotope Completes Private Placement Of Shares And Warrants For US$0.3 Million

297

16.4.12 Enzo Biochem Announces Public Offering Of Common Stock For US$18 Million .............................. 298

16.4.13 Advanced Medical Isotope Completes Private Placement Of Shares And Warrants For US$0.5 Million

300

16.4.14 Navidea Biopharma Completes Private Placement Of Shares For US$5 Million ................................ 301

16.4.15 MRI Interventions Completes Private Placement Of Common Stock For US$11 Million .................... 303

16.4.16 LipoScience Completes IPO For US$52 Million .................................................................................. 304

16.4.17 Navidea Biopharma Completes Private Placement Of Shares For US$2 Million Upon Exercise Of

Warrants 306

16.4.18 FluoroPharma Medical Completes First Tranche Of Private Placement Of Shares For US$2 Million 308

16.4.19 Arrayit Diagnostics Announces Private Placement Of Shares For US$8 Million ................................. 309

16.4.20 MRI Interventions Completes Private Placement Of Units For US$6 Million ....................................... 310




16.4.21 MicroVision Completes Public Offering Of Units For US$10.5 Million ................................................. 311

16.4.22 MRI Interventions Completes IPO ........................................................................................................ 313

16.4.23 Advanced Medical Isotope Completes First Tranche Of Private Placement Of Units For US$0.05

Million 314

16.4.24 Imaging3 Announces Private Placement Of Common Stock For US$0.8 Million ................................ 315

16.4.25 MicroVision Completes Private Placement Of Shares For US$5 Million ............................................. 316

16.4.26 ProUroCare Medical Completes Private Placement Of Shares For US$0.43 Million .......................... 317

16.4.27 VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million .............. 318

16.5 Merger .......................................................................................................................................................... 319

16.5.1 MSC Care Management Completes Merger With One Call Medical ................................................... 319

16.5.2 Tornado Medical Systems Completes Merger With Arjae Spectral Enterprises ................................. 321

16.6 Partnerships ................................................................................................................................................. 322

16.6.1 MRI Interventions Enters Into Co-Development Agreement With Siemens Medical Solutions ........... 322

16.6.2 MRI Interventions Terminates Co-Development Agreement With Siemens Healthcare ..................... 324

16.6.3 Fovia Enters Into Co-Development Agreement With Visual Medica ................................................... 325

16.6.4 CorTechs Labs Extends Distribution Agreement With Invivo For NeuroQuant ................................... 326

16.6.5 P-Cure Enters Into Development Agreement With Philips Healthcare ................................................ 327

16.6.6 Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner .................................... 328

16.6.7 RaySearch Labs Terminates Licensing Agreement With TomoTherapy ............................................. 329

16.6.8 RadioMedix Enters Into Distribution Agreement With ITG Isotope Technologies ............................... 330

16.6.9 Siemens Healthcare Enters Into Co-Development Agreement With Pfizer ......................................... 331

16.6.10 Bracco Imaging Enters Into Co-Marketing Agreement With PHS Technologies For DoseMonitor ..... 333

16.6.11 Imaging Dynamics To Enter Into Co-Marketing Agreement With Kangda Medical ............................. 334

16.6.12 VuCOMP Enters Into Agreement With Konica Minolta ........................................................................ 335

16.6.13 KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain

Proteinopathies ...................................................................................................................................................... 336

16.6.14 IMRIS Enters Into Technology Integration Agreement With Stryker .................................................... 337

16.6.15 Positron Enters Into Licensing Agreement With Institute for Nuclear Research For Radiostrontium

Production Technology .......................................................................................................................................... 338

16.6.16 Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics ..................... 340

16.6.17 Carestream Enters Into Co-Development Agreement With Buffalo Bills ............................................. 341

16.6.18 Bluechiip Enters Into Distribution Agreement With Mitegen ................................................................ 343

16.6.19 GE Healthcare And Konica Minolta Enter Into Global Distribution Agreement For AeroDR ............... 344

16.6.20 Sonomed Escalon Enters Into Technology Integration Agreement With First Insight ......................... 345

16.6.21 Radialogica Enters Into Licensing Agreement With Philips Healthcare ............................................... 346

16.6.22 Daylight Solutions Enters Into Licensing Agreement With Corning ..................................................... 347

16.6.23 Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform .............. 348

16.6.24 Electrical Geodesics Enters Into Distribution Agreement With Hitachi Medical Systems America ..... 350

16.6.25 MiTeGen Enters Into Development And Distribution Agreement With EMBL Enterprise .................... 351




16.6.26 Icahn School of Medicine at Mount Sinai Enters Into Co-Development Agreement With Rensselaer

Polytechnic Institute For Diagnostic Tools............................................................................................................. 352

16.6.27 Positron And Biologics Modular Enter Into Co-Marketing Agreement For PosiRx System ................. 354

16.6.28 UltraSPECT Enters Into Distribution Agreement With PharmaLogic ................................................... 355

16.6.29 SonaCare Medical Enters Into Integration Agreement With UCL Business For Prostate Cancer

Treatment System ................................................................................................................................................. 356

16.6.30 Toshiba Enters Into Agreement With Shands HealthCare And Keck Medical Center For MR Research

358

16.6.31 Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False

Neurotransmitters .................................................................................................................................................. 359

16.6.32 Advanced Medical Isotope Enters Into Co-Development Agreement With GSG International ........... 360

16.6.33 Invivo Enters Into Co-Development Agreement With iCAD For MRI Solutions ................................... 361

16.6.34 Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion

System 362

16.6.35 Philips Enters Into Technology Integration Agreement With Biosense Webster ................................. 363

16.6.36 Bluechiip Enters Into Licensing Agreement With Mitegen For Cryopins ............................................. 364

16.6.37 ImaginAb Exercises Option For Licensing Agreement With Oxford BioMedica To License Vivo 5T4-

Based Imaging Diagnostic ..................................................................................................................................... 365

16.6.38 GE Healthcare Enters Into Licensing Agreement With University of Wisconsin For CT Scan Protocols

366

16.6.39 GE Healthcare Enters Into Agreement With Core Sound Imaging To Distribute Studycast ................ 367

16.6.40 Optimal Radiology Forms Joint Venture With Advanced Diagnostic Imaging ..................................... 368

16.6.41 Imorgon Enters Into Technology Integration Agreement With TomTec Imaging Systems .................. 369

16.6.42 Canon Enters Into Co-Development Agreement With Massachusetts General Hospital And Brigham

and Women‘s Hospital ........................................................................................................................................... 370

16.6.43 Siemens Enters Into Co-Development Agreement With Varian Medical For Imaging Products ......... 372

16.6.44 NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents ... 374

16.6.45 Imorgon Enters Into Integration Agreement With Clickview................................................................. 375

16.6.46 NeoChord Enters Into Licensing Agreement With Robarts Research Institute ................................... 376

16.6.47 Bioventus Enters Into Agreement With Esaote North America For Diagnostic Ultrasound And MRI

Solutions 377

16.6.48 Alliance Healthcare Partners With Emory Healthcare For Diagnostic Imaging Facility ....................... 378

16.6.49 GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging

And Diagnostics ..................................................................................................................................................... 379

16.6.50 Carestream Health Enters Into Co-Development Agreement With Rutgers University ....................... 381

16.6.51 IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben ......... 382

16.6.52 Molecular Targeting Technologies Enters Into Licensing Agreement With Medical College of

Wisconsin For 99mTc-HYNIC-Duramycin ............................................................................................................. 383

16.6.53 Intermountain Healthcare Enters Into Agreement With GE Healthcare ............................................... 384

16.6.54 ActiViews Enters Into Agreement With NeuroLogica To Develop Surgical Navigation System .......... 386

16.6.55 Vascular Solutions Enters Into Distribution Agreement With VueTek Scientific For Veinsite .............. 387




16.6.56 Sectra Enters Into Distribution Agreement With Mammography Reporting System For MRS7

Integrated With Breast Imaging PACS .................................................................................................................. 388

16.6.57 Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid ................................. 389

16.6.58 M*Modal Enters Into Technology Integration Agreement With DataPhysics Research ...................... 390

16.6.59 Accuray Enters Into Co-Development Agreement With German Cancer Research Center ................ 391

16.6.60 Carestream Health Enters Into Co-Development Agreement With Beatson Institute for Cancer

Research 392

16.6.61 Royal Philips Enters Into Co-Development Agreement With St. Joseph‘s Hospital ............................ 393

16.6.62 Varian Medical Systems Enters Into Co-Marketing Agreement With Siemens Healthcare ................. 394

16.6.63 Abbott Vascular Enters Into Co-Marketing Agreement With St. Jude Medical .................................... 396

16.6.64 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET

Tracer System ....................................................................................................................................................... 398

16.6.65 Ground Fluor Pharma Enters Into Licensing Agreement With NUtech Ventures ................................ 399

16.6.66 Aspect Imaging Enters Into Agreement With Bruker For MRI Systems .............................................. 400

16.7 Private Equity ............................................................................................................................................... 402

16.7.1 TPG Capital And Fosun Pharma To Acquire Chindex International For US$369 Million .................... 402

16.7.2 Salt Creek Capital Acquires Ultra Solutions ......................................................................................... 404

16.7.3 Onex Reportedly Calls Off Auction Of Carestream Health For US$3.5 Billion .................................... 405

16.7.4 Psilos Acquires Clinical Imaging Division Of Gamma Medica For US$3.1 Million .............................. 407

16.7.5 JLL Partners Completes Acquisition Of BioClinica, Provider Of Clinical Trial Management Solutions,

For US$123 Million ................................................................................................................................................ 408

16.7.6 Shore Capital Invests In Fast Pace Urgent Care ................................................................................. 410

16.7.7 Cephasonics Acquires Ultrasound Business Unit From Samplify Systems ......................................... 411

16.8 Venture Financing ........................................................................................................................................ 412

16.8.1 Bruin Biometrics Raises US$10 Million In Venture Financing ............................................................. 412

16.8.2 Seno Medical Instruments Raises US$26 Million In Extended Series C Financing ............................ 413

16.8.3 Burl Concepts To Raise US$2 Million In Venture Financing ................................................................ 414

16.8.4 Evena Medical Raises US$5 Million In Series B Financing ................................................................. 415

16.8.5 DxNow Raises Funds Through Seed Financing .................................................................................. 416

16.8.6 Dilon Technologies Raises US$4 Million In Venture Financing ........................................................... 417

16.8.7 ViewRay Raises US$30 Million In Venture Financing ......................................................................... 418

16.8.8 Blaze Bioscience Raises US$9 Million In Series B Financing ............................................................. 420

16.8.9 Veran Medical Raises US$3 Million In Venture Financing ................................................................... 421

16.8.10 ViewRay Raises US$15 Million In Venture Financing ......................................................................... 422

16.8.11 Cerevast Therapeutics Raises US$1.8 Million In Venture Financing .................................................. 423

16.8.12 Phi Optics Raises US$0.25 Million In Seed Financing ........................................................................ 424

16.8.13 TechDevice Raises Funds Through Venture Financing ...................................................................... 425

16.8.14 EchoPixel Raises US$2.35 Million In Seed Financing ......................................................................... 426

16.8.15 Sabik Medical Raises US$0.8 Million In Venture Financing ................................................................ 427




16.8.16 Monteris Medical Raises US$8.3 Million In Venture Financing ........................................................... 428

16.8.17 Sofie Biosciences Raises US$5 Million In Series A Financing Round ................................................ 430

16.8.18 BioNano Genomics Raises US$10 Million In Venture Financing ........................................................ 431

16.8.19 KeyMed Imaging To Raise US$2 Million In Venture Financing ........................................................... 433

16.8.20 Delphinus Medical Technologies Raises US$11 Million In Series B Financing................................... 434

16.8.21 Traycer Diagnostic Systems Raises US$2.8 Million In Venture Financing .......................................... 435

16.8.22 CorTechs Labs Raises US$2 Million In Venture Financing ................................................................. 436

16.8.23 Gamma Medica Raises US$16 Million Series A Financing ................................................................. 437

16.8.24 Lantos Technologies Raises US$5.1 Million In Venture Financing ..................................................... 438

16.8.25 Mirabilis Medica Raises US$4 Million In Series A-1 Financing ........................................................... 439

16.8.26 Clear Guide Medical To Raise US$0.5 Million In Venture Financing .................................................. 440

16.8.27 Mobisante Raises US$4 Million In Series A Venture Financing .......................................................... 441

16.8.28 Sonivate Medical Raises US$0.13 Million In Venture Financing ......................................................... 442

16.8.29 Sonivate Medical Raises US$0.8 Million In Venture Financing ........................................................... 443


16.8.31 Clear Vascular Raises US$0.3 Million In Venture Financing ............................................................... 445

16.8.32 Active Life Scientific Raises US$0.5 Million In Series A Financing ..................................................... 446

16.8.33 Ninepoint Medical Plans To Raise US$35 Million In Series B Financing ............................................ 447

16.8.34 ViewRay Raises US$15 Million In Series D-2 Financing ..................................................................... 448

16.8.35 OraMetrix Raises US$0.2 Million In Venture Financing ....................................................................... 449

16.8.36 Companion Diagnostics To Raise US$1 Million In Venture Financing ................................................ 450

16.8.37 Epic Research & Diagnostics Raises US$1.4 Million In Venture Financing ........................................ 451

16.8.38 Cerevast Therapeutics Raises US$1.5 Million In Venture Financing .................................................. 452

16.8.39 dBMEDx Raises US$1.1 Million In Second Round Of Financing ........................................................ 453

16.8.40 Integrated Biometrics Raises US$0.44 Million In Venture Financing .................................................. 454

16.8.41 Intrinsic Medical Imaging To Raise US$15 Million In Venture Financing ............................................ 455

16.8.42 Mirabilis Medica Raises US$0.5 Million In Venture Financing ............................................................. 456

16.8.43 Strategic Polymer Sciences Raises US$6.6 Million In Series B Financing ......................................... 457

16.8.44 CVUS Clinical Trials To Raise US$7.5 Million In Venture Financing ................................................... 458

16.8.45 Mirabilis Medica Raises US$0.06 Million In Venture Financing ........................................................... 459

16.8.46 Hubble Telemedical Raises US$0.3 Million In Venture Financing ....................................................... 460

16.8.47 Ortho Kinematics Raises More Than US$2 Million In Series B Financing .......................................... 461

16.8.48 Integrated Biometrics Raises US$0.17 Million In Venture Financing .................................................. 462

16.8.49 Avelas Biosciences Raises US$7.7 Million In Series A Financing ...................................................... 463

16.8.50 Precision Through Imaging Raises US$0.13 Million In Venture Financing ......................................... 464

16.8.51 Naviscan Raises US$1 Million In Venture Financing ........................................................................... 465

16.8.52 ViewRay Raises US$11 Million In Series D-1 Financing ..................................................................... 466

16.8.53 Applied BioCode Raises US$7 Million In Series A Financing .............................................................. 467




16.8.54 Imanin To Raise US$0.025 Million In Seed Financing ......................................................................... 468

16.8.55 Epic Research Raises US$0.8 Million In Venture Financing ............................................................... 469

16.8.56 ZetrOZ Raises US$4.5 Million In Venture Financing ........................................................................... 470

16.8.57 PartTec Raises US$0.6 Million In Venture Financing .......................................................................... 471

16.8.58 Serene Oncology Raises US$0.3 Million In Venture Financing ........................................................... 472

16.8.59 SR One Plans To Invest In Biotechnology Company .......................................................................... 473

16.8.60 Quantason Raises US$3.2 Million In Series B Financing .................................................................... 474

16.8.61 Oncoscope Raises US$0.45 Million In Venture Financing .................................................................. 475

16.8.62 Dbmedx Raises Funds Through Seed Financing Round ..................................................................... 476

16.8.63 Traycer Diagnostic Systems Raises US$0.5 Million In Venture Financing .......................................... 477

16.8.64 ABT Molecular Imaging Raises US$6 Million In Series C Financing ................................................... 478

16.8.65 NorthStar Medical Technologies Raises US$5 Million In Series D Financing ..................................... 480

16.8.66 Tribogenics Raises Additional US$4.2 Million In Series A Financing .................................................. 481

16.8.67 Raydiance Raises US$20 Million In Venture Financing ....................................................................... 482

16.8.68 ABT Molecular Imaging Raises US$0.2 Million In Venture Financing ................................................. 484

16.8.69 First Warning Systems Raises US$1 Million In Series A Financing .................................................... 485

16.8.70 Foundation Radiology Raises US$0.5 Million In Venture Financing ................................................... 486

16.8.71 Lucidux Raises US$0.25 Million In Seed Financing Round ................................................................. 487

16.8.72 Marval Biosciences Raises US$2.5 Million In Venture Financing ....................................................... 488

16.8.73 Ikonisys Raises US$0.1 Million In Venture Financing .......................................................................... 489

16.8.74 Iheart Raises US$1.1 Million In Venture Financing ............................................................................. 490

16.8.75 Diagnostic Photonics Raises US$0.41 Million In Venture Financing ................................................... 491

16.8.76 BioNano Genomics Raises US$10 Million In Series B-1 Financing .................................................... 492


16.8.78 BioNano Genomics Raises US$8.8 Million In Venture Financing ....................................................... 495

16.8.79 U-Systems Raises US$5 Million In Venture Financing ........................................................................ 496

16.8.80 U-Systems Raises US$3 Million In Venture Financing ........................................................................ 497

16.8.81 Blaze Bioscience Raises US$8.5 Million In Series A Financing .......................................................... 498

16.8.82 Signa MRI Imaging To Raise US$0.05 Million In Venture Financing .................................................. 499

16.8.83 Penrith Raises US$1.5 Million In Venture Financing ........................................................................... 500

16.8.84 Monteris Medical Raises US$17 Million In Series D Financing ........................................................... 501

16.8.85 Foundation Radiology Raises Additional US$0.04 Million In Venture Financing ................................ 503

16.8.86 ImaginAb Raises US$12.5 Million In Series A Financing .................................................................... 504

16.8.87 Microlytic Raises US$3.5 Million In Venture Financing ........................................................................ 506

16.8.88 ViewRay, Medical Device Company Raises US$45 Million In Series C Financing ............................. 507

16.8.89 Seno Medical Instruments Raises Additional US$7 Million In Series C Financing .............................. 509

17 Recent Developments ...................................................................................................................................... 510

17.1 Corporate Communications ......................................................................................................................... 510




17.1.1 Feb 25, 2014: Molecular Imaging Services Appoints Dr. Gary Heller as Chief Medical Officer .......... 510

17.1.2 Feb 25, 2014: AMAG Pharmaceuticals Appoints Edward Jordan As Senior Vice President Of Sales

And Marketing ........................................................................................................................................................ 510

17.1.3 Feb 24, 2014: Melanoma Diagnostic Provider, MELA Sciences Receives 180-Day Extension to Meet

NASDAQ Minimum Bid Price ................................................................................................................................ 511

17.1.4 Feb 24, 2014: iCAD Appoints Dr. Robert Goodman to Board of Directors .......................................... 511

17.1.5 Feb 20, 2014: R. Andrew Eckert Elected Chairman of Board of Directors of Varian Medical Systems

512

17.1.6 Feb 19, 2014: Navidea Biopharmaceuticals Adds New Member to Board of Directors ...................... 513

17.1.7 Feb 19, 2014: Magellan Complete Care of Florida Hiring Up to 200 Positions ................................... 513

17.1.8 Feb 18, 2014: Cancer Genetics is Pleased to Announce the Appointment of Dr. Paul Rothman, Dean

of the Medical Faculty and CEO of Johns Hopkins Medicine, to Its Board of Directors ....................................... 514

17.1.9 Feb 18, 2014: Kimball International Announces Appointment of Robert F. Schneider to the Company‘s

Board of Directors .................................................................................................................................................. 514

17.1.10 Feb 06, 2014: OPKO Health Announces the Appointment of Greg Stanley as Vice President of Sales

and Marketing for its Global Diagnostics Business Unit ........................................................................................ 515

17.1.11 Feb 04, 2014: Brent Shafer appointed Chief Executive Officer of Philips North America ................... 516

17.1.12 Feb 03, 2014: Canon U.S.A. Announces Senior Executive Appointments and Promotions for New Year

516

17.1.13 Jan 27, 2014: Akers Biosciences Announces Appointment of Non-Executive Director ...................... 517

17.1.14 Jan 22, 2014: LipoScience Announces Appointment of Howard Doran as President and Chief

Executive Officer .................................................................................................................................................... 517

17.1.15 Jan 13, 2014: Caliber Imaging & Diagnostics Appoints Daniel Mark Siegel, M.D. to Its Board of

Directors 518

17.1.16 Jan 09, 2014: Radius Announces Key Changes to Management Team ............................................. 519

17.1.17 Jan 08, 2014: EOS imaging Appoints Chief Medical Officer ............................................................... 520

17.1.18 Jan 07, 2014: AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of

Human Resources ................................................................................................................................................. 520

17.1.19 Jan 06, 2014: Cancer Genetics Appoints John Pappajohn Chairman of the Board of Directors ........ 521

17.1.20 Jan 06, 2014: MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member ........... 522

17.1.21 Jan 03, 2014: Kimball International Announces Appointment of New Independent Director; Timothy

Jahnke to Join Board in February 2014................................................................................................................. 522

17.1.22 Jan 02, 2014: MELA Sciences Appoints Healthcare Executive Jeff O‘Donnell as Director and

Streamlines Board to Support Refocused Go-to-Market Strategy; Richard Steinhart Resigns as CFO ............... 523

17.1.23 Dec 19, 2013: Cancer Genetics Strengthens Its Diagnostics Sales Team With Seasoned Industry

Leader 523

17.1.24 Dec 18, 2013: Molecular Imaging initiates search for Director, Oncology pharmaco-IMAGING ......... 524

17.1.25 Dec 17, 2013: Radius Names Robert Ward President and Chief Executive Officer ........................... 525

17.1.26 Dec 17, 2013: Yvonne Daugherty Joins MedSolutions as Vice President of Marketing ..................... 526

17.1.27 Dec 16, 2013: Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian

CEO Dow Wilson Names Sunny Sanyal as Kluge's Successor ............................................................................ 526




17.1.28 Dec 11, 2013: T2 Biosystems Strengthens Management Team as Company Prepares for Launch of

Flagship T2Candida Diagnostic Test ..................................................................................................................... 527

17.1.29 Dec 09, 2013: Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer ......... 528

17.1.30 Dec 09, 2013: Hologic Expands its Board of Directors with Appointment of Two Independent Directors

and Engages Chairman of Mt. Sinai Radiology Department as Scientific Advisor ............................................... 529

17.1.31 Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President ......................................... 530

17.1.32 Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical‘s Peripheral Intervention

Clinical Division ...................................................................................................................................................... 530

17.1.33 Dec 04, 2013: Immunomedics Announces Outcome of 2013 Annual Meeting of Stockholders ......... 531

17.1.34 Dec 03, 2013: Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto ............ 532

17.1.35 Nov 25, 2013: Caliber Imaging & Diagnostics Appoints Robert P. Fischmann as VP of Operations, a

Newly Created Position ......................................................................................................................................... 532

17.1.36 Nov 25, 2013: iCAD Promotes CFO Kevin Burns to Chief Operating Officer ...................................... 533

17.1.37 Nov 25, 2013: ImaginAb Expands Scientific Advisory Board .............................................................. 533

17.1.38 Nov 21, 2013: PerkinElmer Announces Executive Appointment ......................................................... 534

17.1.39 Nov 20, 2013: Caliber Imaging & Diagnostics Appoints Steven M. Ridge and Ben J. Alexander as

Regional Sales Managers for West and Midwest .................................................................................................. 534

17.1.40 Nov 19, 2013: Seno Medical Instruments Names Dr. Thomas Stavros Medical Director ................... 535

17.1.41 Nov 18, 2013: Regina E. Dugan Appointed to Board of Directors of Varian Medical Systems ........... 536

17.1.42 Nov 18, 2013: Veran Medical Technologies welcomes new member to its board of directors ........... 536

17.1.43 Nov 15, 2013: Navidea Biopharmaceuticals adds new member to board of directors ........................ 537

17.1.44 Nov 14, 2013: Positron Appoints Joseph Oliverio As President .......................................................... 537

17.1.45 Nov 14, 2013: Radius Announces Leadership Transitions With Focus on Late-Stage Growth .......... 538

17.1.46 Nov 13, 2013: Novelos Therapeutics Announces a Restructuring of Its Board of Directors and

Additional Changes to Its Management Team ...................................................................................................... 539

17.1.47 Nov 12, 2013: MedSolutions announces TJ Fjelseth as senior vice president of human resources .. 540

17.1.48 Nov 07, 2013: Medical Device Executive Joins Kona Medical as Chief Medical Officer ..................... 541

17.1.49 Nov 06, 2013: MELA Sciences Appoints Rose Crane as President and Chief Executive Officer and a

Director, Effective as of Monday, November 11th ................................................................................................. 541

17.1.50 Nov 06, 2013: Accelerate Diagnostics Names Mark C. Miller to Board of Directors ........................... 542

17.1.51 Nov 04, 2013: David Stoller, M.D., F.A.C.R. Joins RadNet as National Director of Orthopaedic and

Musculoskeletal Imaging ....................................................................................................................................... 542

17.1.52 Oct 29, 2013: AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of

Medical and Scientific Affairs ................................................................................................................................. 543

17.1.53 Oct 28, 2013: FluoroPharma Medical, Inc. Names GE Healthcare Veteran, Edward L. Lyons, Jr. to

Newly Created Position of Vice President, Marketing ........................................................................................... 543

17.1.54 Oct 28, 2013: HealthHelp Adds Leading Oncology Expert, Dr. Cindy Ippoliti, to Enhance the

Company‘s Oncology Program .............................................................................................................................. 544

17.1.55 Oct 23, 2013: Banner Medical names Chief Operating Officer ............................................................ 546

17.1.56 Oct 21, 2013: Kimball Office Announces New Officer; Mike Wagner Appointed Vice President, General

Manager 546




17.1.57 Oct 15, 2013: IDEXX Laboratories Names Brian McKeon Executive Vice President and Chief Financial

Officer 547

17.1.58 Oct 15, 2013: Kimball International Holds Annual Meeting of Share Owners and Declares Dividend 547

17.1.59 Oct 14, 2013: Former FDA commissioner, Mark McClellan, to Join Johnson & Johnson board of

directors 548

17.1.60 Oct 11, 2013: Kenin M. Spivak Elected Vice Chairman of Board of Directors of Advanced Medical

Isotope 549

17.1.61 Oct 09, 2013: Novelos Appoints Industry Veteran to Lead Strategic Realignment ............................. 549

17.1.62 Oct 09, 2013: Optimal Radiology Hires Veteran Imaging Executive Joseph McDonough as CEO .... 550

17.1.63 Oct 04, 2013: SpectraScience Appoints Lowell Giffhorn to be Chief Financial Officer ....................... 551

17.1.64 Oct 03, 2013: Hoya Appoints Ganesh Ramaswamy Global President of PENTAX Medical ............... 551

17.1.65 Oct 01, 2013: MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Dr. Darrell Rigel as

Chief Medical Advisor to Its Board of Directors ..................................................................................................... 551

17.1.66 Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group .................. 552

17.1.67 Sep 30, 2013: MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Tony Dimun to Its

Board of Directors .................................................................................................................................................. 553

17.1.68 Sep 25, 2013: AliMed Appoints Scott C. Lewis as Chief Executive Officer ......................................... 554

17.1.69 Sep 10, 2013: CardiacAssist Launches Protek17 Arterial Cannula ..................................................... 554

17.1.70 Sep 09, 2013: AMAG Pharmaceuticals Announces Appointment of Barbara Deptula to Board of

Directors 555

17.1.71 Sep 06, 2013: LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical

Officer 555

17.1.72 Sep 04, 2013: SonaCare Medical Expands Management Team With Chief Financial Officer ............ 556

17.1.73 Sep 03, 2013: Immunomedics Appoints Peter P. Pfreundschuh as New Chief Financial Officer ....... 557

17.1.74 Sep 03, 2013: Accuray Incorporated CFO Resigns Accuray Appoints Successor .............................. 557

17.1.75 Aug 28, 2013: LDR Secures First FDA Clearance For Two-level Cervical Disc Replacement ........... 558

17.1.76 Aug 28, 2013: OPKO Health Announces Listing in Major Indices on Tel Aviv Stock Exchange ......... 560

17.1.77 Aug 26, 2013: Echometrix Appoints Chief Executive Officer ............................................................... 560

17.1.78 Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic

Intervention Clinical Division .................................................................................................................................. 561

17.1.79 Aug 20, 2013: Immunomedics Appoints Richard L. Sherman to Board of Directors ........................... 561

17.1.80 Aug 20, 2013: Novant Health announces new senior vice president of marketing and communications

562

17.1.81 Aug 19, 2013: Provista Diagnostics Appoints Chief Commercial Officer ............................................. 563

17.1.82 Aug 19, 2013: OPKO Health Announces New Listing on Tel Aviv Stock Exchange ........................... 563

17.1.83 Aug 12, 2013: Veteran Ultrasound Executive Joins Kona Medical ...................................................... 564

17.1.84 Aug 09, 2013: LipoScience Announces Appointment Of Vice President, General Counsel And

Corporate Secretary .............................................................................................................................................. 565

17.1.85 Aug 08, 2013: LipoScience Announces Two New Members of Board of Directors ............................. 565

17.1.86 Aug 07, 2013: MELA Sciences To Cut 25% Jobs ................................................................................ 566

17.1.87 Aug 02, 2013: LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer 566




17.1.88 Aug 02, 2013: Pitt Associate Vice Chancellor Maddy Ross to Retire Effective August 31, 2013 ....... 567

17.1.89 Aug 01, 2013: Solis Women's Health Mammography Names Stephen L. Rose, M.D. as Chief Medical

Officer 568

17.1.90 Jul 31, 2013: Alliance HealthCare Services Names Percy C. Tom Tomlinson, Jr. as Chief Executive

Officer 569

17.1.91 Jul 29, 2013: Novelos Therapeutics Announces Leadership Transition .............................................. 570

17.1.92 Jul 29, 2013: Canon U.S.A. Names Tsuneo Imai President of Virtual Imaging ................................... 571

17.1.93 Jul 29, 2013: Richard I. Fisher, MD, Named President and CEO of Fox Chase Cancer Center......... 571

17.1.94 Jul 24, 2013: CellScape Names Ted Snelgrove as Chief Executive Officer ........................................ 572

17.1.95 Jul 23, 2013: AMAG Pharmaceuticals Appoints Carol Satler, M.D., Ph.D. as Senior Vice President of

Medical and Scientific Affairs ................................................................................................................................. 573

17.1.96 Jul 18, 2013: Hologic Appoints Jack W. Cumming President and Chief Executive Officer ................. 573

17.1.97 Jul 16, 2013: OPKO Health Announces Appointment of David Okrongly, Ph.D. as President of its

Diagnostics Business Unit ..................................................................................................................................... 574

17.1.98 Jul 16, 2013: David S. Herron Joins BioClinica To Lead Imaging Core Lab Division .......................... 575

17.1.99 Jul 15, 2013: Toshiba Names X-Ray Vascular Business Unit Director ............................................... 575

17.1.100 Jul 15, 2013: Navidea Biopharmaceuticals Announces Board Member Resignation ...................... 576

17.1.101 Jul 15, 2013: IDEXX Laboratories Elects Sophie Vandebroek to Board of Directors ...................... 576

17.1.102 Jul 15, 2013: Banner Health welcomes new pulmonologist............................................................. 577

17.1.103 Jul 15, 2013: Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2013 ............. 577

17.1.104 Jul 11, 2013: Lantheus Medical Imaging Announces Chief Financial Officer Transition ................. 577

17.1.105 Jul 10, 2013: Solis Women's Health Names Reese B. Walter Jr. as Chief Development Officer ... 578

17.1.106 Jul 03, 2013: AMAG Pharmaceuticals Appoints Amit Verma as Vice President of Marketing ........ 579

17.1.107 Jul 02, 2013: Alliance HealthCare Services Added to Russell 3000 Index ...................................... 579

17.1.108 Jul 01, 2013: Matthew G. Molchan Assumes the CEO Role at Digirad ........................................... 580

17.1.109 Jun 24, 2013: AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and

Regulatory Officer .................................................................................................................................................. 580

17.1.110 Jun 17, 2013: Mela Sciences Announces Senior Management Changes ....................................... 581

17.1.111 Jun 12, 2013: PLC Systems Announces Changes to Its Board of Directors ................................... 581

17.1.112 Jun 06, 2013: T2 Biosystems Appoints Marc Jones As CFO .......................................................... 582

17.1.113 May 29, 2013: Imaging3 Confirms Chapter 11 Reorganization Plan ............................................... 583

17.1.114 May 09, 2013: Bayer HealthCare Eliminates 50 Jobs At Medrad .................................................... 583

17.1.115 Apr 25, 2013: Johnson & Johnson Announces Dividend Increase of 8.2% ..................................... 583

17.1.116 Apr 23, 2013: MicroVision Appoints Stephen P Holt As CFO .......................................................... 584

17.1.117 Apr 19, 2013: ProUroCare Appoints Stan Myrum As Interim CEO .................................................. 584

17.1.118 Apr 16, 2013: MRI Interventions Elects Dr. Philip A. Pizzo to Board of Directors ........................... 585

17.1.119 Apr 15, 2013: FluoroPharma Announces Appointment of Dr. Joseph A. Pierro to the Board of

Directors 585

17.1.120 Apr 10, 2013: Rotech Receives First Day Motions Approval From US Bankruptcy Court .............. 586

17.1.121 Apr 03, 2013: HealthSouth to Hold Annual Stockholder Meeting .................................................... 587




17.1.122 Apr 02, 2013: Gentag Receives Canadian Patent For Smart Wireless Skin Patch ......................... 587

17.1.123 Mar 27, 2013: Banner Health Saves $226m With Premier Healthcare Alliance .............................. 588

17.1.124 Mar 26, 2013: Harbor MedTech Receives FDA Clearance For Architect Advanced Collagen Matrix

588

17.1.125 Mar 06, 2013: Lantheus Medical Imaging Appoints Cesare Orlandi As CMO ................................. 589

17.2 Financial Announcements ............................................................................................................................ 590

17.2.1 Feb 26, 2014: Digirad Reports Fourth Quarter and Year-End Financial Results ................................ 590

17.2.2 Feb 25, 2014: Neodyne Biosciences Partners with The Strouse Corporation to Scale Production of

embrace Advanced Scar Therapy ......................................................................................................................... 591

17.2.3 Feb 24, 2014: Merit Medical Reports Record Revenues for the Quarter and Year Ended December 31,

2013 592

17.2.4 Feb 24, 2014: Volcano Reports Fourth Quarter Revenues Increase Six Percent On A Constant

Currency Basis ...................................................................................................................................................... 594

17.2.5 Feb 19, 2014: iCAD Reports 2013 Fourth Quarter and Full Year Financial Results ........................... 595

17.2.6 Feb 19, 2014: HealthSouth Reports Strong Results for Fourth Quarter and Full Year 2013 .............. 596

17.2.7 Feb 18, 2014: Precision Optics Announces Operating Results for the Second Quarter and Six Months

Ended December 31, 2013 .................................................................................................................................... 598

17.2.8 Feb 18, 2014: Bruker Reports Fourth Quarter and Full Year 2013 Financial Results ......................... 599

17.2.9 Feb 14, 2014: FONAR Announces Fiscal 2014 Second Quarter Earnings Results ............................ 600

17.2.10 Feb 13, 2014: Corgenix Reports Second Quarter Fiscal 2014 Financial Results ............................... 602

17.2.11 Feb 13, 2014: VCA Antech Reports Fourth Quarter 2013 Results and Provides Financial Guidance for

2014 602

17.2.12 Feb 10, 2014: Immunomedics Announces Second Quarter Fiscal 2014 Results ............................... 604

17.2.13 Feb 06, 2014: EOS imaging Announces Two EOS System Installations in Paris AP-HP Public

Hospitals 605

17.2.14 Feb 05, 2014: Kimball International Reports Second Quarter Fiscal Year 2014 Results .................... 606

17.2.15 Feb 05, 2014: Misonix Announces Second Quarter Fiscal Year 2014 Financial Results ................... 607

17.2.16 Feb 04, 2014: IDEXX Laboratories Announces Fourth Quarter and Full-Year Financial Results ....... 608

17.2.17 Feb 03, 2014: Digirad Announces Quarterly Dividend of $0.05 Per Share ......................................... 610

17.2.18 Feb 03, 2014: Hologic Announces First Quarter Fiscal 2014 Operating Results ................................ 610

17.2.19 Jan 30, 2014: PerkinElmer Announces Financial Results for the Fourth Quarter of 2013 .................. 612

17.2.20 Jan 30, 2014: Accuray Reports Financial Results for Second Quarter of Fiscal Year 2014 ............... 613

17.2.21 Jan 28, 2014: Danaher Reports Record Fourth Quarter And Full Year 2013 Results ........................ 615

17.2.22 Jan 24, 2014: Gagnon Cardiovascular Institute At Morristown Medical Center Implants Newly

Approved Device To Replace Failing Aortic Heart Valves .................................................................................... 615

17.2.23 Jan 24, 2014: PerkinElmer Board Declares Quarterly Dividend .......................................................... 618

17.2.24 Jan 22, 2014: EOS imaging Announces 61% Revenue Surge in 2013 to €15.2 Million ..................... 618

17.2.25 Jan 22, 2014: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2014 .......... 619

17.2.26 Jan 21, 2014: Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results ................... 620

17.2.27 Jan 14, 2014: EndoChoice Announces Health Canada License for Fuse Endoscopy System in Canada

622




17.2.28 Jan 13, 2014: Volcano Announces Preliminary Fourth Quarter 2013 Revenues; YearOverYear Annual

Revenues Increase Eight Percent On A Constant Currency Basis ....................................................................... 623

17.2.29 Jan 08, 2014: HealthSouth Announces Date Of 2013 Fourth Quarter Earnings Conference Call ...... 624

17.2.30 Jan 07, 2014: Accuray to Report Financial Results for Second Quarter Fiscal 2014 .......................... 625

17.2.31 Jan 07, 2014: Danaher Schedules Fourth Quarter 2013 Earnings Conference Call ........................... 625

17.2.32 Jan 06, 2014: Varian Medical Systems Publishes 2013 Annual Report on Investor Web Site ........... 625

17.2.33 Dec 17, 2013: Magellan Health Services to Release 2014 Financial Guidance on December 17, 2013

625

17.2.34 Dec 10, 2013: Enzo Biochem Reports First Fiscal Quarter Results .................................................... 626

17.2.35 Dec 09, 2013: Enzo Biochem Schedules Teleconference to Discuss First Quarter Results Wednesday,

December 11, 2013 at 8:30 AM E.T. ..................................................................................................................... 627

17.2.36 Dec 09, 2013: Analogic Announces Financial Results for the First Quarter Ended October 31, 2013

and Declares Quarterly Cash Dividend ................................................................................................................. 627

17.2.37 Dec 04, 2013: Jabil's First Quarter of Fiscal Year 2014 Earnings Announcement Set ....................... 628

17.2.38 Nov 27, 2013: Study Suggests Non-Invasive Stereotactic Ablative Body Radiotherapy May Be Suitable

Alternative to Surgery for Early-Stage Lung Cancer Patients ............................................................................... 629

17.2.39 Nov 21, 2013: European Medicines Agency Accepts Marketing Authorization Application for The

Medicines Company's Fibrocaps Hemostatic Agent ............................................................................................. 629

17.2.40 Nov 21, 2013: LipoScience to Discuss 2014 Guidance on Fourth Quarter 2013 Financial Results

Conference Call ..................................................................................................................................................... 630

17.2.41 Nov 21, 2013: Analogic announces timing for first quarter 2014 earnings conference call and webcast

630

17.2.42 Nov 19, 2013: Diagnostic Imaging International Corp. 2013 Q3 financial results................................ 631

17.2.43 Nov 18, 2013: Precision Optics Announces Operating Results for the First Quarter of Fiscal Year 2014

ended September 30, 2013 ................................................................................................................................... 631

17.2.44 Nov 15, 2013: Corgenix Reports First Quarter Fiscal 2014 Financial Results .................................... 632

17.2.45 Nov 15, 2013: FONAR Announces First Fiscal 2014 Quarter Earnings Results ................................. 633

17.2.46 Nov 15, 2013: Advanced Medical Isotope to Discuss Third Quarter 2013 Financial Results and Provide

a General Business Update ................................................................................................................................... 635

17.2.47 Nov 14, 2013: Fort Worth‘s Ampcare Earns FDA Approval For ESP, A Treatment For Swallowing

Disorders 635

17.2.48 Nov 14, 2013: Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of

2013 637

17.2.49 Nov 13, 2013: Cancer Genetics, Inc. announces third quarter financial results .................................. 639

17.2.50 Nov 12, 2013: MicroVision announces third quarter 2013 results ....................................................... 640

17.2.51 Nov 12, 2013: GenMark Diagnostics Reports Third Quarter 2013 Results ......................................... 641

17.2.52 Nov 12, 2013: MRI Interventions Announces Third Quarter 2013 Financial Results .......................... 643

17.2.53 Nov 11, 2013: Cancer Genetics Announces Conference Call to Discuss Third Quarter Results ........ 645

17.2.54 Nov 11, 2013: RadNet Reports Third Quarter Financial Results ......................................................... 645

17.2.55 Nov 11, 2013: Chindex International, Inc. reports financial results for third quarter and first nine months

of 2013 646

17.2.56 Nov 11, 2013: Hologic Announces Fourth Quarter Fiscal 2013 Operating Results ............................ 648




17.2.57 Nov 07, 2013: Misonix Announces First Quarter Fiscal Year 2014 Financial Results ........................ 650

17.2.58 Nov 07, 2013: Accuray Reports Financial Results for First Quarter of Fiscal Year 2014 .................... 651

17.2.59 Nov 06, 2013: Navidea Biopharmaceuticals Announces Third Quarter 2013 Results ........................ 652

17.2.60 Nov 06, 2013: Alliance HealthCare Services Reports Third Quarter 2013 Results ............................. 655

17.2.61 Nov 06, 2013: Lantheus Medical Imaging to Host Third Quarter 2013 Conference Call on November

13, 2013 at 3:00 p.m. Eastern Time ...................................................................................................................... 656

17.2.62 Nov 06, 2013: MELA Sciences reports third quarter 2013 results and launch of new strategic plan .. 656

17.2.63 Nov 05, 2013: Vasomedical to Report Third Quarter 2013 Results on November 14, 2013 ............... 658

17.2.64 Nov 05, 2013: Corgenix to Host Conference Call to Discuss First Quarter Results ............................ 658

17.2.65 Nov 05, 2013: Kimball International Reports First Quarter Fiscal Year 2014 Results ......................... 659

17.2.66 Nov 05, 2013: LipoScience Reports Third Quarter 2013 Financial Results ........................................ 660

17.2.67 Nov 05, 2013: Chindex International Clarifies Timing of Release of 3Q13 Earnings Results ............. 662

17.2.68 Nov 05, 2013: Symbion Announces Third Quarter 2013 Conference Call .......................................... 662

17.2.69 Nov 04, 2013: Threshold Pharmaceuticals Reports Third Quarter 2013 Financial and Operational

Results 662

17.2.70 Nov 04, 2013: HealthSouth Announces Date of 2011 Fourth Quarter Earnings Conference Call ...... 664

17.2.71 Nov 04, 2013: Immunomedics Announces First Quarter Fiscal 2014 Results .................................... 664

17.2.72 Nov 04, 2013: Misonix To Report Financial Results For The First Quarter Of Fiscal Year 2014 On

Thursday, November 7, 2013 ................................................................................................................................ 665

17.2.73 Nov 04, 2013: Volcano Reports Third Quarter Results ........................................................................ 665

17.2.74 Nov 04, 2013: MicroVision Schedules Third Quarter 2013 Conference Call ....................................... 667

17.2.75 Oct 30, 2013: Alliance Healthcare Services Schedules Conference Call and Webcast to Review Third

Quarter 2013 Financial Results ............................................................................................................................. 668

17.2.76 Oct 30, 2013: PerkinElmer Announces Financial Results for the Third Quarter of 2013 .................... 668

17.2.77 Oct 30, 2013: Navidea Biopharmaceuticals Schedules Third Quarter 2013 Financial Results

Conference Call ..................................................................................................................................................... 669

17.2.78 Oct 29, 2013: GenMark Diagnostics Schedules Third Quarter 2013 Financial Results Conference Call

for November 12, 2013 .......................................................................................................................................... 669

17.2.79 Oct 29, 2013: MRI Interventions to Report Third Quarter 2013 Financial Results .............................. 670

17.2.80 Oct 28, 2013: iCAD Reports Third Quarter Financial Results ............................................................. 670

17.2.81 Oct 28, 2013: Volcano Corporation Announces Third Quarter 2013 Revenues, Updated Revenue

Guidance For Full Year 2013 And Preliminary Revenue Guidance For 2014 ...................................................... 672

17.2.82 Oct 28, 2013: HealthSouth Reports Solid Results for Third Quarter 2013 and Raises Full-Year

Guidance 673

17.2.83 Oct 24, 2013: Hologic to Release Fourth Quarter Fiscal 2013 Operating Results on Monday,

November 11, 2013 ............................................................................................................................................... 674

17.2.84 Oct 24, 2013: Magellan Health Services Reports Third Quarter 2013 Financial Results .................... 675

17.2.85 Oct 24, 2013: Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2014

Financial Results ................................................................................................................................................... 675

17.2.86 Oct 24, 2013: PerkinElmer Board Declares Quarterly Dividend .......................................................... 676

17.2.87 Oct 24, 2013: VCA Antech Reports Third Quarter 2013 Results ......................................................... 676




17.2.88 Oct 23, 2013: AMAG Reports Third Quarter and Nine Month 2013 Financial Results ........................ 677

17.2.89 Oct 23, 2013: Merit Medical Announces Results for the Quarter Ended September 30, 2013 ........... 679

17.2.90 Oct 23, 2013: Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2013 ....... 681

17.2.91 Oct 22, 2013: LipoScience to Release Third Quarter Fiscal Year 2013 Financial Results ................. 683

17.2.92 Oct 22, 2013: IDEXX Laboratories Announces Third Quarter Results ................................................ 683

17.2.93 Oct 22, 2013: Varian Medical Systems to Host Fourth Quarter Earnings Webcast Live on Wednesday,

October 23, 2013 ................................................................................................................................................... 685

17.2.94 Oct 22, 2013: iCAD to Host Third Quarter Financial Results Conference Call on Tuesday, October 29,

2013 685

17.2.95 Oct 21, 2013: Volcano Corporation Schedules Third Quarter Conference Call, Webcast .................. 685

17.2.96 Oct 18, 2013: DGT Holdings Reports Preliminary Fiscal 2013 Fourth Quarter And Fiscal Year

Financial Results And Accelerated Termination Of Rights Agreement ................................................................. 685

17.2.97 Oct 17, 2013: Bruker Announces Date and Time of Third Quarter 2013 Earnings Release and

Webcast 686

17.2.98 Oct 17, 2013: AMAG Pharmaceuticals to Host Conference Call on October 23, 2013 at 8:00 a.m. ET to

Discuss Financial Results for the Quarter Ended September 30, 2013 ................................................................ 687

17.2.99 Oct 17, 2013: Danaher Reports Record Third Quarter 2013 Results .................................................. 687

17.2.100 Oct 15, 2013: MELA Sciences to Release Third Quarter 2013 Financial Results and Host

Conference Call on Wednesday, November 6, 2013 ............................................................................................ 688

17.2.101 Oct 15, 2013: Digirad to Release 2013 Third Quarter and Nine-Month Financial Results on

November 1, 2013 ................................................................................................................................................. 688

17.2.102 Oct 15, 2013: Enzo Biochem Reports Fourth Quarter and Fiscal Year Results .............................. 689

17.2.103 Oct 15, 2013: Johnson & Johnson Reports 2013 Third-Quarter Results ........................................ 690

17.2.104 Oct 14, 2013: Accuray to Report Financial Results for First Quarter Fiscal 2014 ........................... 692

17.2.105 Oct 09, 2013: IDEXX Laboratories to Release 2013 Third Quarter Financial Results .................... 692

17.2.106 Oct 07, 2013: Varian Medical Systems Schedules Fourth Quarter FY2013 News Release and

Conference Call ..................................................................................................................................................... 692

17.2.107 Oct 07, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call

Information for the Third Quarter Ended September 30, 2013 .............................................................................. 692

17.2.108 Oct 02, 2013: FONAR Announces Fiscal 2013 Year End Results .................................................. 692

17.2.109 Oct 01, 2013: Precision Optics Announces Operating Results for the Fourth Quarter and Year

Ended June 30, 2013 ............................................................................................................................................ 693

17.2.110 Sep 30, 2013: Study Demonstrates Significant Clinical and Economic Impact of Nanosphere's

Verigene Blood Culture Test ................................................................................................................................. 694

17.2.111 Sep 30, 2013: Corgenix Reports Fiscal 2013 Financial Results ...................................................... 696

17.2.112 Sep 27, 2013: Scientific Industries Reports Increased Earnings for Fiscal 2013 and a Cash Dividend

697

17.2.113 Sep 25, 2013: Kelyniam Global turns profitable during the second quarter of 2013 ....................... 697

17.2.114 Sep 20, 2013: HealthSouth Announces Date Of 2013 Third Quarter Earnings Conference Call.... 698

17.2.115 Sep 18, 2013: Misonix To Report Financial Results For The Fourth Quarter And Fiscal Year 2013

On Tuesday, September 24, 2013 ........................................................................................................................ 698

17.2.116 Sep 18, 2013: Corgenix to Host Conference Call to Discuss Fiscal 2013 Results .......................... 698




17.2.117 Sep 12, 2013: Magellan Health Services Announces Third Quarter 2013 Earnings Conference Call

698

17.2.118 Sep 12, 2013: HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred

Stock 699

17.2.119 Sep 12, 2013: Analogic Announces Financial Results for the Fourth Quarter and Fiscal Year Ended

July 31, 2013 and Declares Quarterly Cash Dividend ........................................................................................... 699

17.2.120 Sep 11, 2013: Danaher Announces Quarterly Dividend .................................................................. 701

17.2.121 Aug 28, 2013: EOS imaging Reports First Half 2013 Results ......................................................... 701

17.2.122 Aug 27, 2013: Accuray Announces Results for Fourth Quarter and Fiscal Year 2013 ................... 702

17.2.123 Aug 22, 2013: Akers Biosciences Announces Interim Results for the Six Months Ended 30 June

2013 703

17.2.124 Aug 22, 2013: Analogic Announces Timing for Fourth Quarter and Fiscal Year End 2013 Earnings

Conference Call and Webcast ............................................................................................................................... 706

17.2.125 Aug 22, 2013: Immunomedics Announces Fiscal 2013 Results ...................................................... 706

17.2.126 Aug 15, 2013: Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial

Results and Provide a Business Update ............................................................................................................... 708

17.2.127 Aug 14, 2013: PLC Systems Reports Second Quarter 2013 Financial Results .............................. 708

17.2.128 Aug 13, 2013: Vasomedical Announces Financial Results for the Second Quarter of 2013 ........... 710

17.2.129 Aug 09, 2013: Immunomedics Announces Conference Call and Webcast for Fourth Quarter and

Fiscal Year 2013 Financial Results ....................................................................................................................... 711

17.2.130 Aug 09, 2013: OPKO Announces Second Quarter 2013 Operating and Financial Highlights ........ 711

17.2.131 Aug 09, 2013: RadNet Reports Second Quarter Financial Results and Reaffirms 2013 Full-Year

Guidance 712

17.2.132 Aug 09, 2013: OPKO Announces Second Quarter 2013 Operating and Financial Highlights ........ 714

17.2.133 Aug 08, 2013: MicroVision Announces Second Quarter 2013 Results ........................................... 715

17.2.134 Aug 07, 2013: Navidea Biopharmaceuticals Announces Second Quarter 2013 Results ................ 717

17.2.135 Aug 07, 2013: Chindex International Reports Financial Results for Second Quarter and First Half of

2013 719

17.2.136 Aug 07, 2013: GenMark Diagnostics Reports Second Quarter 2013 Results ................................. 721

17.2.137 Aug 07, 2013: Accuray to Report Financial Results for Fourth Quarter and Year End Fiscal 2013 722

17.2.138 Aug 06, 2013: Vasomedical to Report Second Quarter 2013 Results on August 13, 2013 ............ 722

17.2.139 Aug 06, 2013: LipoScience Reports Second Quarter 2013 Financial Results ................................ 723

17.2.140 Aug 06, 2013: MRI Interventions to Report Second Quarter 2013 Financial Results ..................... 725

17.2.141 Aug 05, 2013: Volcano Reports Second Quarter Results; Medical Segment Revenues Increase

More Than 13 Percent On A Constant Currency Basis ......................................................................................... 725

17.2.142 Aug 05, 2013: Cancer Genetics Announces Second Quarter 2013 Financial Results .................... 726

17.2.143 Aug 05, 2013: Hologic Announces Third Quarter Fiscal 2013 Operating Results ........................... 728

17.2.144 Aug 01, 2013: Threshold Pharmaceuticals Reports Second Quarter 2013 Financial and Operational

Results 730

17.2.145 Aug 01, 2013: Lantheus Medical Imaging to Host Second Quarter 2013 Conference Call on August

8, 2013 at 4:00 p.m. Eastern Time ........................................................................................................................ 731

17.2.146 Aug 01, 2013: PerkinElmer Announces Financial Results for the Second Quarter of 2013 ............ 731




17.2.147 Aug 01, 2013: AMAG Announces Second Quarter and Six Month 2013 Financial Results ............ 733

17.2.148 Aug 01, 2013: Digirad Corporation Reports Second Quarter and Six-Month Financial Results ..... 735

17.2.149 Aug 01, 2013: MicroVision Schedules Second Quarter 2013 Conference Call ............................... 736

17.2.150 Aug 01, 2013: Kimball International Reports Fourth Quarter and Fiscal Year 2013 Results .......... 737

17.2.151 Jul 31, 2013: RadNet Announces Date of Its Second Quarter 2013 Earnings Conference Call ..... 738

17.2.152 Jul 31, 2013: Alliance HealthCare Services Reports Results for the Second Quarter Ended June 30,

2013 738

17.2.153 Jul 31, 2013: Bruker Corporation Reports Second Quarter 2013 Financial Results ....................... 740

17.2.154 Jul 31, 2013: Merit Medical Reports Record Revenues, up Nine Percent, for the Quarter and Six

Months Ended June 30, 2013 ................................................................................................................................ 742

17.2.155 Jul 30, 2013: AMAG Pharmaceuticals to Host Conference Call on August 1, 2013 at 8:00 a.m. ET to

Discuss Financial Results for the Quarter Ended June 30, 2013 .......................................................................... 744

17.2.156 Jul 29, 2013: GenMark Diagnostics Schedules Second Quarter 2013 Financial Results Conference

Call for August 7, 2013 .......................................................................................................................................... 744

17.2.157 Jul 29, 2013: iCAD Reports Second Quarter Financial Results ...................................................... 744

17.2.158 Jul 29, 2013: Chindex International to Report Second Quarter and First Half of 2013 Financial

Results 746

17.2.159 Jul 26, 2013: PerkinElmer Board Declares Quarterly Dividend ....................................................... 747

17.2.160 Jul 25, 2013: Navidea Biopharmaceuticals to Announce Second Quarter 2013 Financial Results

Pre-market on Wednesday, August 7, 2013 ......................................................................................................... 747

17.2.161 Jul 25, 2013: Magellan Health Services Reports Second Quarter 2013 Financial Results ............. 747

17.2.162 Jul 25, 2013: HealthSouth Reports Strong Results for Second Quarter 2013 and Raises Full-Year

Guidance 748

17.2.163 Jul 24, 2013: Alliance HealthCare Services Schedules Conference Call and Webcast to Review

Second Quarter 2013 Financial Results ................................................................................................................ 749

17.2.164 Jul 24, 2013: Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2013 ...... 750

17.2.165 Jul 23, 2013: IDEXX Laboratories Announces Second Quarter Results ......................................... 751

17.2.166 Jul 23, 2013: LipoScience to Release Second Quarter Fiscal Year 2013 Financial Results .......... 753

17.2.167 Jul 22, 2013: Bruker Announces Date and Time of Second Quarter 2013 Earnings Release and

Webcast 753

17.2.168 Jul 19, 2013: Volcano Corporation Schedules Second Quarter Conference Call, Webcast ........... 753

17.2.169 Jul 19, 2013: iCAD to Host Second Quarter Financial Results Conference Call on Tuesday, July 30,

2013 754

17.2.170 Jul 18, 2013: Digirad Corporation to Release 2013 Second Quarter and Six-Month Financial Results

on August 1, 2013 .................................................................................................................................................. 754

17.2.171 Jul 18, 2013: Danaher Reports Record Second Quarter 2013 Results ........................................... 754

17.2.172 Jul 17, 2013: EOS imaging First Half 2013 Sales More Than Double ............................................. 755

17.2.173 Jul 17, 2013: MELA Sciences, a Leader in the Fight Against Melanoma, to Release Second Quarter

2013 Financial Results and Host Conference Call on Wednesday, August 7, 2013 ............................................ 755

17.2.174 Jul 16, 2013: Johnson & Johnson Reports 2013 Second-Quarter Results ..................................... 756

17.2.175 Jul 15, 2013: IDEXX Laboratories to Release 2013 First Quarter Financial Results ...................... 758




17.2.176 Jul 08, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call

Information for the Second Quarter Ended June 30, 2013.................................................................................... 758

17.2.177 Jun 27, 2013: SpectraScience Announces Q2 2013 Revenue ........................................................ 758

17.2.178 Jun 26, 2013: Hologic to Release Third Quarter Fiscal 2013 Operating Results on Monday, August

5, 2013 758

17.2.179 Jun 25, 2013: Johnson & Johnson to Host Conference Call on Second-Quarter Results .............. 758

17.2.180 Jun 19, 2013: WellStar Health System To Implement Capsule's DataCaptor Software .................. 759

17.2.181 Jun 18, 2013: HealthSouth Announces Date Of 2013 Second Quarter Earnings Conference Call 759

17.2.182 Jun 10, 2013: Enzo Biochem Reports Revenue Of $22.6m In Q3 Fiscal 2013 ............................... 759

17.2.183 Jun 06, 2013: Enzo Biochem Schedules Teleconference to discuss Third Quarter Results on June

11, 2013 761

17.2.184 Jun 05, 2013: Pioneer Surgical Launches Streamline MIS Spinal Fixation System ........................ 761

17.2.185 Jun 04, 2013: Analogic Reports Revenue Of $125.8m In Q3 Fiscal 2013 ...................................... 761

17.2.186 May 20, 2013: Precision Optics Reports Q3 Fiscal 2013 Results ................................................... 762

17.2.187 May 15, 2013: Vasomedical Reports Revenue Of $7.3m In Q1 2013 ............................................. 763

17.2.188 May 15, 2013: PLC Systems Reports Q1 2013 Results .................................................................. 764

17.2.189 May 15, 2013: Fonar Reports Revenue Of $11.6m In Q3 Fiscal 2013 ............................................ 764

17.2.190 May 15, 2013: Novelos Therapeutics Reports Q1 2013 Results ..................................................... 766

17.2.191 May 15, 2013: FluoroPharma Reports Q1 2013 Results ................................................................. 767

17.2.192 May 15, 2013: Cancer Genetics Announces First Quarter 2013 Financial Results and Significant

Business and Portfolio Progress ........................................................................................................................... 768

17.2.193 May 14, 2013: Corgenix Medical Reports Revenue Of $2.5m In Q3 Fiscal 2013 ........................... 770

17.2.194 May 14, 2013: Radius Health Reports Q1 2013 Results ................................................................. 770

17.2.195 May 10, 2013: RadNet Reports Revenue Of $172.9m In Q1 2013 ................................................. 771

17.2.196 May 10, 2013: Cancer Genetics Announces Conference Call to Discuss First Quarter Results .... 773

17.2.197 May 09, 2013: LipoScience Reports Revenue Of $13.6m In Q1 2013 ............................................ 773

17.2.198 May 09, 2013: Opko Health Reports Revenue Of $31.4m In Q1 2013 ........................................... 775

17.2.199 May 09, 2013: Misonix Reports Revenue Of $3m In Q3 Fiscal 2013 .............................................. 776

17.2.200 May 09, 2013: MRI Interventions Announces First Quarter 2013 Financial Results ....................... 777

17.2.201 May 08, 2013: Navidea Reports Q1 2013 Results ........................................................................... 779

17.2.202 May 08, 2013: GenMark Diagnostics Reports Revenue Of $11.1m In Q1 2013 ............................. 780

17.2.203 May 08, 2013: Chindex International Reports Revenue Of $41.6m In Q1 2013 ............................. 781

17.2.204 May 08, 2013: Immunomedics Reports Q3 Fiscal 2013 Results ..................................................... 782

17.2.205 May 07, 2013: Accuray Reports Revenue Of $70.5m In Q3 Fiscal 2013 ........................................ 784

17.2.206 May 06, 2013: Hologic Reports Revenue Of $612.7m In Q2 Fiscal 2013 ....................................... 785

17.2.207 May 06, 2013: Digirad Corporation Reports First Quarter Financial Results ................................... 785

17.2.208 May 02, 2013: Volcano Reports Revenue Of $93.2m In Q1 2013 .................................................. 787

17.2.209 May 02, 2013: Kimball International Reports Revenue Of $301.5m In Q3 Fiscal 2013 .................. 787

17.2.210 May 02, 2013: Threshold Pharma Reports Revenue Of $2.9m In Q1 2013 .................................... 788




17.2.211 May 02, 2013: MicroVision Announces First Quarter 2013 Results ................................................ 790

17.2.212 May 02, 2013: Bruker Corporation Reports First Quarter 2013 Financial Results .......................... 791

17.2.213 May 01, 2013: Alliance HealthCare Services Reports Revenue Of $110.4m In Q1 2013 ............... 792

17.2.214 Apr 30, 2013: Magellan Health Services Reports Revenue Of $821.8m In Q1 2013 ...................... 792

17.2.215 Apr 30, 2013: Mela Sciences Reports Q1 2013 Results .................................................................. 793

17.2.216 Apr 29, 2013: iCAD Reports Revenue Of $7.9m In Q1 2013 .......................................................... 793

17.2.217 Apr 29, 2013: MRI Interventions to Report First Quarter 2013 Financial Results............................ 794

17.2.218 Apr 26, 2013: DJOFL Reports Revenue Of $279.1m In Q1 2013 ................................................... 794

17.2.219 Apr 25, 2013: PerkinElmer Reports Revenue Of $505.4m In Q1 2013 ........................................... 796

17.2.220 Apr 25, 2013: Merit Medical Reports Revenue Of $103.9m In Q1 2013 ......................................... 797

17.2.221 Apr 25, 2013: HealthSouth Reports Revenue Of $572.6m In Q1 2013 ........................................... 799

17.2.222 Apr 24, 2013: Amag Pharma Reports Revenue Of $17.9m In Q1 2013 .......................................... 800

17.2.223 Apr 24, 2013: Varian Medical Reports Revenue Of $768.4m In Q2 Fiscal 2013 ............................ 801

17.2.224 Apr 24, 2013: Coherent Reports Revenue Of $200.1m In Q2 Fiscal 2013 ..................................... 802

17.2.225 Apr 24, 2013: Given Imaging to Host First Quarter 2013 Financial Results Conference Call on May

9, 2013 803

17.2.226 Apr 23, 2013: Idexx Labs Reports Revenue Of $332.1m In Q1 2013 ............................................. 803

17.2.227 Apr 18, 2013: Danaher Reports Revenue Of $4.4 Billion In Q1 2013 ............................................. 804

17.2.228 Apr 16, 2013: Johnson & Johnson Reports Revenue Of $17.5 Billion In Q1 2013 ......................... 805

17.2.229 Apr 02, 2013: Diagnostic Imaging International Corp. 2012 Financial Results ................................ 807

17.2.230 Apr 02, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call

Information for the First Quarter Ended March 31, 2013 ....................................................................................... 807

17.2.231 Apr 01, 2013: Vasomedical Reports Revenue Of $29.2m In 2012 .................................................. 808

17.2.232 Mar 28, 2013: PLC Systems Reports Revenue Of $1.1m In 2012 .................................................. 809

17.2.233 Mar 28, 2013: FluoroPharma Reports 2012 Results ....................................................................... 810

17.2.234 Mar 28, 2013: Novelos Therapeutics Reports 2012 Results ........................................................... 811

17.2.235 Mar 28, 2013: HealthSouth Announces Date Of 2013 First Quarter Earnings Conference Call ..... 812

17.2.236 Mar 27, 2013: LipoScience Reports Revenue Of $54.8m In 2012 .................................................. 813

17.2.237 Mar 19, 2013: Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results ...... 815

17.2.238 Mar 18, 2013: Opko Health Reports Revenue Of $47m In 2012 ..................................................... 815

17.2.239 Mar 15, 2013: Radius Health Reports 2012 Results ........................................................................ 817

17.2.240 Mar 13, 2013: Alliance HealthCare Services Reports Revenue Of $472m In 2012 ........................ 817

17.2.241 Mar 13, 2013: DGT Holdings Reports Q2 Fiscal 2013 Results ....................................................... 819

17.2.242 Mar 13, 2013: Chindex International, Inc. Reports Fourth Quarter and Full Year 2012 Financial

Results 819

17.2.243 Mar 12, 2013: RadNet Reports Revenue Of $647.2m In 2012 ........................................................ 821

17.2.244 Mar 12, 2013: GenMark Diagnostics Reports Revenue Of $20.5m In 2012 ................................... 823

17.2.245 Mar 12, 2013: Enzo Biochem Reports Revenue Of $22.2m In Q2 Fiscal 2013 .............................. 824

17.2.246 Mar 11, 2013: BiO2 Medical Announces First Placement Of Triple Lumen Angel Catheter In EU . 825




17.2.247 Mar 11, 2013: Analogic Reports Revenue Of $138.6m In Q2 Fiscal 2013 ...................................... 826

17.2.248 Mar 07, 2013: MRI Interventions Reports Revenue Of $5.1m In 2012 ............................................ 827

17.2.249 Mar 05, 2013: Mela Sciences Reports 2012 Results ....................................................................... 828

17.3 Government and Public Interest ................................................................................................................... 829

17.3.1 Feb 25, 2014: Cutting-Edge Medical Imaging Technology Now Available to Phoenix Area Residents

829

17.3.2 Feb 18, 2014: Single chip device to provide real-time 3-D images from inside the heart, blood vessels

829

17.3.3 Jan 21, 2014: BC Technical Signs Agreement With HealthTrust To Provide Refurbished Medical

Imaging Equipment ................................................................................................................................................ 830

17.3.4 Jan 09, 2014: AMAG Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare

Conference ............................................................................................................................................................ 831

17.3.5 Jan 08, 2014: Cancer Genetics to Present at Two Investor Conferences in January ......................... 831

17.3.6 Jan 08, 2014: PerkinElmer to Hold Earnings Call on Thursday, January 30, 2014 ............................. 831

17.3.7 Jan 08, 2014: Danaher to Present at J.P. Morgan Healthcare Conference ........................................ 832

17.3.8 Jan 08, 2014: Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to

the U.S. FDA Regarding Naming of Biosimilars .................................................................................................... 832

17.3.9 Jan 07, 2014: Navidea Biopharmaceuticals to Present at 2014 Biotech Showcase Conference........ 833

17.3.10 Jan 07, 2014: GenMark Diagnostics to Present at the 32nd Annual J.P. Morgan Healthcare

Conference ............................................................................................................................................................ 833

17.3.11 Jan 07, 2014: Medigus to Present its Unique SRS Technology at the Needham Growth Conference on

January 15, 2014 ................................................................................................................................................... 833

17.3.12 Jan 07, 2014: iCAD to Participate in the 16th Annual Needham Growth Conference ......................... 833

17.3.13 Jan 07, 2014: SonaCare Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference

833

17.3.14 Jan 06, 2014: Chindex International to Present at 32nd Annual J.P. Morgan Healthcare Conference

834

17.3.15 Jan 06, 2014: Volcano Corporation Presentation At J.P. Morgan Conference To Be Webcast .......... 834

17.3.16 Jan 06, 2014: T2 Biosystems to Present at the 32nd Annual J.P. Morgan Healthcare Conference ... 835

17.3.17 Jan 06, 2014: Accuray to Present at JP Morgan 32nd Annual Healthcare Conference ...................... 835

17.3.18 Jan 03, 2014: Analogic to Present at Upcoming Investor Conferences .............................................. 835

17.3.19 Dec 30, 2013: National Expert Panel Gives Lung Cancer Screening Official Green Light .................. 835

17.3.20 Dec 18, 2013: Johnson & Johnson to Host Fourth-Quarter/Full-Year 2013 Earnings Meeting ........... 836

17.3.21 Dec 16, 2013: OPKO Announces Investor Conference Call Details ................................................... 836

17.3.22 Dec 13, 2013: OPKO To Hold Investor Conference ............................................................................ 836

17.3.23 Dec 11, 2013: Analogic to Present at Imperial Capital Security Investor Conference ......................... 836

17.3.24 Dec 10, 2013: Varian Medical Systems Schedules First Quarter FY2014 News Release and

Conference Call ..................................................................................................................................................... 837

17.3.25 Dec 05, 2013: T2 Biosystems to Present at Oppenheimer‘s 24th Annual Healthcare Conference .... 837

17.3.26 Dec 04, 2013: OPKO Health to Present at the Oppenheimer 24th Annual Healthcare Conference ... 837




17.3.27 Dec 03, 2013: Threshold Pharmaceuticals Announces Presentation and Webcast at the Oppenheimer

24th Annual Healthcare Conference ..................................................................................................................... 839

17.3.28 Dec 03, 2013: Chindex International to Present Oppenheimer 24th Annual Healthcare Conference . 839

17.3.29 Dec 03, 2013: Immunomedics to Present at Oppenheimer 24th Annual Healthcare Conference ...... 839

17.3.30 Dec 02, 2013: Navidea Biopharmaceuticals to Host Analyst Science Day December 5, 2013 in New

York City 839

17.3.31 Nov 29, 2013: RadNet to Present at the Bank of America Merrill Lynch 2013 Leveraged Finance

Conference on December 3, 2013 ........................................................................................................................ 840

17.3.32 Nov 27, 2013: LipoScience to present at 25th Annual Piper Jaffray Healthcare Conference ............. 840

17.3.33 Nov 27, 2013: FluoroPharma Medical to Present at the LD Micro Sixth Annual Conference on

December 5, 2013 ................................................................................................................................................. 840

17.3.34 Nov 27, 2013: LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference ............. 840

17.3.35 Nov 27, 2013: HealthSouth To Present At Investor Conference In December.................................... 841

17.3.36 Nov 26, 2013: iCAD to Participate in the LD Micro Conference .......................................................... 841

17.3.37 Nov 26, 2013: Merit Medical to Participate at Piper Jaffray Healthcare Conference ........................... 841

17.3.38 Nov 26, 2013: Inappropriate to Balance Bill Medicare Patients for Breast Tomosynthesis ................. 841

17.3.39 Nov 25, 2013: Volcano Presentation At Piper Jaffray Conference To Be Webcast ............................ 841

17.3.40 Nov 25, 2013: SpectraScience to Present at the 6th Annual LD Micro Conference ........................... 842

17.3.41 Nov 20, 2013: PerkinElmer to Present at Piper Jaffray Healthcare Conference ................................. 842

17.3.42 Nov 20, 2013: IDEXX Laboratories to Present at Piper Jaffray 25th Annual Healthcare Conference 842

17.3.43 Nov 18, 2013: Accuray to Present at Piper Jaffray 25th Annual Healthcare Conference ................... 842

17.3.44 Nov 15, 2013: AMAG Pharmaceuticals Announces Presentation at Jefferies 2013 Global Healthcare

Conference in London ........................................................................................................................................... 842

17.3.45 Nov 14, 2013: Digirad to present at the 6th annual LD MICRO conference ........................................ 842

17.3.46 Nov 12, 2013: Philips CFO presents at the UBS European Investor Conference in London .............. 843

17.3.47 Nov 12, 2013: Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Week

843

17.3.48 Nov 12, 2013: iCAD to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum

843

17.3.49 Nov 05, 2013: Magellan Health Services to Present at Two Upcoming Health Care Conferences .... 843

17.3.50 Nov 05, 2013: Hologic to Host Investor Presentation at RSNA 2013 .................................................. 844

17.3.51 Nov 05, 2013: Johnson & Johnson to Participate in Credit Suisse 2013 Health Care Conference .... 844

17.3.52 Nov 04, 2013: HealthSouth to Present at Lazard Capital Markets Healthcare Conference ................ 844

17.3.53 Nov 04, 2013: HealthSouth to Present at the 30th Annual J.P. Morgan Healthcare Conference ....... 844

17.3.54 Nov 04, 2013: ImaCor‘s hTEE Recognized as the Advanced Hemodynamic Management Solution in

Critical Care ........................................................................................................................................................... 845

17.3.55 Oct 23, 2013: Misonix Exhibits at the Annual Paradigm Medical Management Meeting .................... 845

17.3.56 Oct 16, 2013: MELA Sciences to Participate in the Fall Clinical Dermatology Conference ................ 846

17.3.57 Oct 16, 2013: Navidea Biopharmaceuticals to Host Analyst Science Day December 5, 2013 in New

York City 847




17.3.58 Oct 08, 2013: Cancer Genetics Will Open Precision Medicine Conference With Keynote Presentation

847

17.3.59 Oct 04, 2013: Cancer Genetics CEO Panna Sharma to Participate in Panel at BioNJ CEO Summit . 847

17.3.60 Oct 01, 2013: RadNet to Present at the Deutsche Bank 21st Annual Leveraged Finance Conference

on October 2, 2013 ................................................................................................................................................ 848

17.3.61 Sep 26, 2013: Analogic Announces Timing of Investor Day Webcast ................................................. 848

17.3.62 Sep 25, 2013: MRI Interventions to Present at 2013 Craig-Hallum Alpha Select Conference ............ 849

17.3.63 Sep 24, 2013: iCAD to Participate in Craig-Hallum‘s 4th Annual Alpha Select Conference ............... 849

17.3.64 Sep 24, 2013: Navidea Biopharmaceuticals to Present at BioCentury‘s NewsMakers in the Biotech

Industry Conference .............................................................................................................................................. 849

17.3.65 Sep 19, 2013: Caliber Imaging & Diagnostics to Present at AdvaMed 2013: The MedTech Conference

on September 24, 2013 ......................................................................................................................................... 849

17.3.66 Sep 17, 2013: Johnson & Johnson to Host Conference Call on Third-Quarter Results ...................... 850

17.3.67 Sep 17, 2013: Danaher Schedules Third Quarter 2013 Earnings Conference Call ............................ 850

17.3.68 Sep 13, 2013: MRI Interventions to Present at UBS 2012 Global Life Sciences Conference ............. 850

17.3.69 Sep 10, 2013: Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities

Conference on September 19, 2013 ..................................................................................................................... 850

17.3.70 Sep 09, 2013: Cancer Genetics Announces Upcoming Investor Conference Schedule ..................... 851

17.3.71 Sep 09, 2013: Danaher to Present at Morgan Stanley Industrials and Autos Conference .................. 851

17.3.72 Sep 05, 2013: Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel

Healthcare Conference 2013 ................................................................................................................................. 851

17.3.73 Sep 04, 2013: Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

851

17.3.74 Sep 04, 2013: Immunomedics to Present at Stifel Healthcare Conference 2013 ............................... 851

17.3.75 Sep 03, 2013: Merit Medical to Present at CL King Conference ......................................................... 852

17.3.76 Aug 28, 2013: Chindex International to Attend Morgan Stanley Global Healthcare Conference ........ 852

17.3.77 Aug 26, 2013: Accuray to Host Investor Meeting at ASTRO 2013 ...................................................... 852

17.3.78 Aug 26, 2013: Roger Williams to host Rally4Recovery kickoff on August 30 ...................................... 852

17.3.79 Aug 26, 2013: HealthSouth To Present At Investor Conferences In September ................................. 853

17.3.80 Aug 26, 2013: PerkinElmer to Present at Morgan Stanley Healthcare Conference ............................ 853

17.3.81 Aug 22, 2013: Accuray to Present at Upcoming Investor Conferences ............................................... 853

17.3.82 Aug 09, 2013: IMRIS CEO Jay D. Miller to present at Canaccord Genuity 33rd Annual Global Growth

Conference ............................................................................................................................................................ 854

17.3.83 Aug 08, 2013: Volcano Presentation At Canaccord Genuity Conference To Be Webcast .................. 854

17.3.84 Aug 07, 2013: Hologic to Present at Two Upcoming Investor Conferences ........................................ 854

17.3.85 Aug 02, 2013: Digirad to Present at the 2013 Southern California Investor Conference .................... 854

17.3.86 Aug 01, 2013: Merit Medical to Participate at Canaccord Genuity Growth Conference ...................... 854

17.3.87 Aug 01, 2013: Urologists Discredit Flawed, Misleading GAO Cancer Treatment Utilization Study..... 855

17.3.88 Jul 25, 2013: The Centers For Medicare & Medicaid Services Draft Decision Could Limit Patient

Access To New Technology That May Help In Diagnosing Dementia .................................................................. 856

17.3.89 Jul 23, 2013: Optimal Radiology Partners to Present at AHRA Annual Meeting ................................. 856




17.3.90 Jul 15, 2013: Insight Genetics featured in Canada‘s Annual Report Card on Cancer, ―Regulatory

Approval and Funding of Precision Medicine in Non-Small Cell Lung Cancer‖ .................................................... 857

17.3.91 Jul 11, 2013: SpectraScience Announces Business Update Conference Call .................................... 857

17.3.92 Jul 02, 2013: Navidea Biopharmaceuticals to Present at the JMP Securities Healthcare Conference

857

17.3.93 Jul 02, 2013: Navidea Biopharmaceuticals to Present at the JMP Securities Healthcare Conference

858

17.3.94 Jul 01, 2013: MRI Interventions to Present at 2013 JMP Securities Healthcare Conference ............. 858

17.3.95 Jun 18, 2013: MRI Screening May Help Identify Spinal Infections From Contaminated Drug Injections

858

17.3.96 Jun 13, 2013: JAMA Pediatrics Study Highlights Cancer Risk Associated With CT Scans ................ 859

17.3.97 Jun 05, 2013: MRI May Be Effective Way To Diagnose Mental Illnesses Such As Bipolar Disorder,

Study Says ............................................................................................................................................................. 860

17.3.98 Jun 05, 2013: HealthSouth To Present At The 2013 Wells Fargo Securities Healthcare Conference 861

17.3.99 Jun 03, 2013: AMAG Pharmaceuticals to Present at Upcoming Investor Conferences ...................... 861

17.3.100 May 31, 2013: Establishing Minimum National Standards And Oversight Framework Would Help

Ensure Quality And Safety Of Advanced Diagnostic Imaging Services, GAO Finds ............................................ 861

17.3.101 May 23, 2013: Cancer Genetics to Present at Marcum MicroCap Conference ............................... 862

17.3.102 May 20, 2013: Cancer Genetics to Attend ASCO Annual Meeting .................................................. 862

17.3.103 May 02, 2013: PLC Systems to Present at Taglich Brothers 10th Annual Small Cap Equity

Conference 863

17.3.104 May 02, 2013: HealthSouth To Present At Investor Conferences In May ....................................... 863

17.3.105 May 01, 2013: Inflammatory Bowel Disease Detection Enhanced With PET/CT, Study Finds ....... 863

17.3.106 Apr 23, 2013: Johnson & Johnson to Host Pharmaceuticals Business Review .............................. 864

17.3.107 Apr 02, 2013: North Carolina Bill Sets Licensing Standards For Personnel Who Perform Radiologic

Procedures 864

17.3.108 Mar 04, 2013: Accuray Announces Highlights From First European Conference On SRS/SBRT And

IG-IMRT Held In Milan ........................................................................................................................................... 865

17.4 Legal And Regulatory ................................................................................................................................... 866

17.4.1 Feb 18, 2014: Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust

and False Advertising Suits Against Division of Johnson & Johnson ................................................................... 866

17.4.2 Jan 28, 2014: Solos Endoscopy Receives ISO 13485:2003 Certification From TUV SUD America .. 866

17.4.3 Jan 28, 2014: Consensys Imaging Service receives certification to ISO 9001:2008 and ISO

13485:2003 quality standards ............................................................................................................................... 867

17.4.4 Jan 22, 2014: Bronstein, Gewirtz & Grossman Announces Investigation of AMAG Pharmaceuticals 867

17.4.5 Jan 07, 2014: Enzo Biochem Announces Upcoming Litigation Schedule ........................................... 868

17.4.6 Jan 06, 2014: Federal Court Awards Enzo Biochem over $61 Million in Patent Infringement Damages

868

17.4.7 Nov 12, 2013: Mindray Announced a Settlement Agreement with Beckman Coulter ......................... 868

17.4.8 Nov 05, 2013: Kelyniam Global Reports Settlement of Lawsuit .......................................................... 869

17.4.9 Nov 05, 2013: AHF: J&J‘s Record $2 Billion Fine Shows Pharma‘s ‗Unbridled Greed‘ ...................... 869

17.4.10 Oct 31, 2013: AHF Sues Johnson & Johnson for Cheating on AIDS Drug Pricing ............................. 869




17.4.11 Oct 11, 2013: Positron's Radioisotope Manufacturing Facility Receives ISO 9001 Certification ........ 870

17.4.12 Oct 08, 2013: Solos Endoscopy Reports Results From Stage 2 of Its ISO 13485 Audit With TUV SUD

America 871

17.4.13 Sep 25, 2013: Bronstein, Gewirtz & Grossman Announces Investigation of AMAG Pharmaceuticals 872

17.4.14 Sep 19, 2013: Johnson & Johnson Earns Global CEO Cancer Gold Standard Accreditation ............ 872

17.4.15 Aug 27, 2013: MRI Diagnostic Testing Company, Imagimed, and Its Former Owners and Chief

Radiologist to Pay $3.57 Million to Resolve False Claims Act Allegations ........................................................... 873

17.4.16 Aug 22, 2013: Solos Endoscopy Completes Stage 2 of its ISO 13485 Audit with TUV SUD America 874

17.4.17 Aug 22, 2013: Several Magellan Care Management Centers Earn Accreditation by the National

Committee for Quality Assurance .......................................................................................................................... 874

17.4.18 Aug 14, 2013: Broad launch for ColdZyme Mouth Spray, soon on Apoteket AB‘s shelves ................ 875

17.4.19 Aug 13, 2013: Elekta: Lawsuit with Varian Medical Systems resolved ................................................ 876

17.4.20 Jul 30, 2013: False Claims Act Judgment Entered Against Washington, DC, Health Care Provider for

More Than $17 Million ........................................................................................................................................... 876

17.4.21 Jul 10, 2013: Zecotek Provides Update on Patent Lawsuit Against Saint-Gobain Corporation and

Philips 877

17.4.22 Jul 01, 2013: Roger Williams Medical Center's Breast Health Program accredited by NAPBC .......... 878

17.4.23 Jul 01, 2013: S.C. Court Grants Judgment to Revolutions Medical and Its CEO ................................ 878

17.4.24 Jun 26, 2013: FDA Approves ACR To Accredit Fuji Aspire HD Plus And Aspire HD–S Full-Field Digital

Systems 879

17.4.25 May 28, 2013: Zecotek Announces Markman Hearing Date For Patent Lawsuit Against Saint-Gobain

And Philips ............................................................................................................................................................. 879

17.4.26 May 01, 2013: OiService CT & MR Earns ISO 9001:2008 & 13485:2003 Recertification ................... 880

17.4.27 Apr 30, 2013: Jefferson County Circuit Court Rules Against HealthSouth In Ernst & Young Arbitration

Appeal 880

17.4.28 Apr 25, 2013: CooperSurgical Gets FDA Warning Letter Regarding Texas Manufacturing Plant ...... 881

17.4.29 Apr 17, 2013: Insight Genetics Gets ISO 9001:2008 Certification ....................................................... 881

17.4.30 Mar 29, 2013: Shine Submits Construction Permit Application For Medical Isotope Plant To NRC ... 882

17.4.31 Mar 05, 2013: HealthSouth's Four Hospitals Receive Document Subpoenas From Health Regulator

882

17.5 Other Significant Developments ................................................................................................................... 883

17.5.1 Feb 18, 2014: Danaher Increases Quarterly Dividend ......................................................................... 883

17.5.2 Feb 14, 2014: HealthSouth Declares Dividend on Common Stock and on 6.5% Series A Convertible

Perpetual Preferred Stock ..................................................................................................................................... 883

17.5.3 Feb 11, 2014: Novelos Therapeutics Announces Corporate Name Change to Cellectar Biosciences

884

17.5.4 Feb 04, 2014: Immunomedics Ranks 4th in the Patent Board Biotechnology Industry Scorecard ..... 885

17.5.5 Jan 31, 2014: Misonix Enhances its Web Presence with the Unveiling of its New Website ............... 885

17.5.6 Jan 30, 2014: Exclusive Distribution Agreement for DNAble and Array Tape ..................................... 886

17.5.7 Jan 27, 2014: AHRA and Toshiba Select 2013 Putting Patients First Grant Recipients ..................... 886

17.5.8 Jan 27, 2014: Varian Medical Systems Announces Imaging Components Supply Agreement with

Toshiba Medical Systems ...................................................................................................................................... 887




17.5.9 Jan 23, 2014: Varian Medical Systems Partners with the Algerian Ministry of Health to Equip Cancer

Centers with Advanced Technology for Radiotherapy and Radiosurgery ............................................................. 888

17.5.10 Jan 22, 2014: Nanotherapeutics selects GE Healthcare Life Sciences technologies for Advanced

Development and Manufacturing Center ............................................................................................................... 889

17.5.11 Jan 21, 2014: Cancer Genetics Awarded $1.8 Million in Non-Dilutive Financing From New Jersey's

Technology Business Tax Certificate Transfer Program ....................................................................................... 889

17.5.12 Jan 16, 2014: Center for Diagnostic Imaging Adds Merge Healthcare's Advanced Interoperability

Platform for Clinical and Operational Workflow Efficiency .................................................................................... 890

17.5.13 Jan 13, 2014: AUXILIO Signs Five-Year Managed Print Services Contract with University of California

at San Diego (UCSD) Health System .................................................................................................................... 890

17.5.14 Jan 07, 2014: Sentara Northern Virginia Medical Center Selects Optimal Radiology Partners .......... 891

17.5.15 Jan 02, 2014: Johnson & Johnson Announces Quarterly Dividend for First Quarter 2014 ................. 891

17.5.16 Jan 02, 2014: U.S. Defense Department Awards Carestream a One-Year, $70.2 Million Contract

Extension for X-ray Imaging Systems ................................................................................................................... 891

17.5.17 Dec 20, 2013: CCFA Partners Inititative Receives Funding From Patient-Centered Outcomes

Research Institute .................................................................................................................................................. 892

17.5.18 Dec 17, 2013: UT researchers awarded $979,120 grant to expand personalized cancer care .......... 893

17.5.19 Dec 11, 2013: Premier Women‘s Radiology Practice Selects Carestream‘s Mammography PACS with

Digital Breast Tomosynthesis Module ................................................................................................................... 894

17.5.20 Dec 09, 2013: Skyworks Launches Customized Optical Solutions for Varian Medical ....................... 895

17.5.21 Dec 03, 2013: Robert Wood Johnson Foundation to Fund NORC at the University of Chicago

Research on the Value of Cost Transparency in Health Care .............................................................................. 895

17.5.22 Nov 27, 2013: Kentucky healthcare system to implement medical image sharing solutions from

lifeIMAGE 896

17.5.23 Nov 22, 2013: Vital Images invests in global expansion as a result of significant growth ................... 897

17.5.24 Nov 21, 2013: Hologic adopts one-year stockholder rights plan ......................................................... 897

17.5.25 Nov 21, 2013: Inland Imaging Selects M*Modal for Clinical Documentation Technology ................... 898

17.5.26 Nov 20, 2013: Bayer HealthCare awards veterinary students $72,500 in scholarship funds for

communications excellence ................................................................................................................................... 899

17.5.27 Nov 18, 2013: Varian Medical Systems board of directors authorizes repurchase of additional 6 million

shares of stock through calendar year 2014 ......................................................................................................... 900

17.5.28 Nov 13, 2013: NGAGE Announces Representation Agreement with SIEMENS Healthcare .............. 900

17.5.29 Nov 04, 2013: HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred

Stock 901

17.5.30 Oct 29, 2013: WYLE SELECTS FUJIFILM TO ACCELERATE WORKFLOW AND ENHANCE

DIAGNOSTIC CONFIDENCE FOR NASA IN-FLIGHT AND GROUND BASED CLINICAL CARE OPERATIONS

901

17.5.31 Oct 25, 2013: Ortho Kinematics Launches New Physician Web Portal ............................................... 902

17.5.32 Oct 25, 2013: HealthSouth Declares Dividend on Common Stock and on 6.5% Series A Convertible

Perpetual Preferred Stock ..................................................................................................................................... 902

17.5.33 Oct 24, 2013: Ortho Kinematics Launches New Physician Web Portal ............................................... 903

17.5.34 Oct 22, 2013: OnPoint Partners With Leading Children's Hospital to Deliver Quality Assurance Solution

903




17.5.35 Oct 17, 2013: Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2013 .............. 903

17.5.36 Oct 03, 2013: DNA nanotechnology opens new path to super-high-resolution molecular imaging..... 904

17.5.37 Oct 01, 2013: RadTek Contracts With uNeed Partners to Provide Engineering Consulting Services on

Their Latest Project the Korea Particle Therapy Cancer Center ........................................................................... 905

17.5.38 Sep 24, 2013: Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant ..... 905

17.5.39 Sep 09, 2013: Digirad Signs Agreement to Outsource Imaging Equipment Manufacturing ................ 906

17.5.40 Sep 09, 2013: NextGxDx Adds Cancer Genetics to Genetic Testing Platform ................................... 906

17.5.41 Sep 05, 2013: Caliber Imaging & Diagnostics Adds Two New Distributors of VivaScope(R) Devices for

Brazilian and Australian/New Zealand Markets ..................................................................................................... 906

17.5.42 Sep 03, 2013: Vital Images, Inc. celebrates 25 years .......................................................................... 907

17.5.43 Aug 23, 2013: RedChip Issues Research Profile on Cancer Genetics ................................................ 908

17.5.44 Aug 20, 2013: Varian Medical Systems Schedules Investor Meeting at ASTRO in Atlanta ................ 908

17.5.45 Aug 19, 2013: Generous donors funding new $1.2 million Center for Breast Health at Billings Clinic 908

17.5.46 Aug 13, 2013: Kimball International Declares Quarterly Dividend ....................................................... 909

17.5.47 Aug 07, 2013: FUJIFILM and the National Breast Cancer Foundation Celebrate Installation of New

State-of-the-Art Mammography Unit at The Rose ................................................................................................. 909

17.5.48 Aug 05, 2013: Optimal Radiology Relocates Headquarters to Nashville ............................................. 910

17.5.49 Aug 05, 2013: Perrigo Nutritionals Works with the American Academy of Pediatrics on Infant Nutrition

Educational Initiative .............................................................................................................................................. 910

17.5.50 Jul 29, 2013: AHRA and Toshiba Launch Sixth Annual Putting Patients First Program ..................... 911

17.5.51 Jul 09, 2013: Foundation Radiology Group Receives $6M Credit Facility from Square 1 Bank ......... 912

17.5.52 Jun 13, 2013: San Antonio Hospital Installs Eight Carestream DR Systems To Help Lower Dose,

Speed Image Access ............................................................................................................................................. 912

17.5.53 May 31, 2013: ArtVentive Medical Gets CE Mark For ArtVentive EOS System .................................. 913

17.5.54 May 29, 2013: TWi Pharmaceuticals's Manufacturing Site For Generic Version Of Lidoderm Patch

Passes FDA cGMP Audit And Pre-Approval Inspection ....................................................................................... 913

17.5.55 May 01, 2013: Carestream Signs Three-Year Contract With Novation For Radiology, Cardiology

Healthcare IT Solutions ......................................................................................................................................... 914

17.5.56 Apr 11, 2013: Johnson & Johnson to Webcast Annual Meeting of Shareholders ............................... 914

17.5.57 Apr 03, 2013: Genomic Health Announces Presentation Of Positive Clinical Validation Study Results

Of Oncotype DX Prostate Cancer Test At 2013 AUA Annual Meeting ................................................................. 915

17.5.58 Apr 02, 2013: Agfa HealthCare Receives Contract From US Navy To Provide End-To-End Imaging

Solution 915

17.5.59 Apr 02, 2013: Clinilabs Launches Subject Authentication Initiative At Its Phase I Sites In New York And

New Jersey ............................................................................................................................................................ 916

17.5.60 Apr 02, 2013: AG Mednet Signs Master Services Agreement With Bio-VisiQ To Provide Zero-Delay

Clinical Trial Solutions To Asian Pharmaceutical Market ...................................................................................... 917

17.5.61 Mar 27, 2013: Kessler Foundation Scientist Receives $619,618 Grant To Study Predictors Of Memory

Decline In Multiple Sclerosis .................................................................................................................................. 917

17.5.62 Mar 19, 2013: Amerinet Signs Three-Year Contract For Carestream‘s Comprehensive Portfolio Of

Digital Imaging Systems ........................................................................................................................................ 918

17.5.63 Mar 19, 2013: Lantheus Medical Imaging Announces Molybdenum-99 Supply Contract With IRE .... 918




17.5.64 Mar 13, 2013: Genomic Health Announces Positive Study Results Of Oncotype DX To Quantify Risk

Of Loco-Regional Recurrence In Node-Positive Breast Cancer Patients ............................................................. 919

17.5.65 Mar 13, 2013: HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred

Stock 920

17.5.66 Mar 11, 2013: Hong Kong Adventist Oncology Center Offers Full Spectrum Of Disease Treatment With

Accuray‘s CyberKnife And TomoTherapy Systems .............................................................................................. 920

17.5.67 Mar 07, 2013: CCOC Purchases Carestream Digital Radiology Systems To Streamline Workflow ... 921

17.6 Product News ............................................................................................................................................... 921

17.6.1 Feb 18, 2014: Philips announces achievement of major milestone in largest ever sleep apnea clinical

trial 921

17.6.2 Feb 17, 2014: Dynamsoft Image Capture Software Used in New Fujifilm Radiology Management

Solution 922

17.6.3 Feb 12, 2014: SonoSim LiveScan Brings Medical Simulation To Life ................................................. 923

17.6.4 Feb 11, 2014: Prexion launches its new 3D product and company website ....................................... 923

17.6.5 Feb 05, 2014: Samsung Announces Launch of Samsung Financial Solutions to Boost Growth of

Health & Medical Equipment Business.................................................................................................................. 924

17.6.6 Feb 04, 2014: Low-Dose Radiation X-Rays Now Available at Stanford Children‘s Health Emeryville 924

17.6.7 Feb 03, 2014: Novel technique increases detection rate in screening mammography ....................... 925

17.6.8 Jan 28, 2014: Varian Medical Systems Joins Global Community in Promoting World Cancer Day.... 926

17.6.9 Jan 23, 2014: Mint Medical Education Announces Knobology Training for the Mindray M7 Ultrasound

System; User Implementation and Basic Scanning Support Available Online Anytime ....................................... 927

17.6.10 Jan 22, 2014: Philips launches new Healthcare Informatics Solutions and Services Business Group

928

17.6.11 Jan 15, 2014: Carestream‘s Research Initiatives Lead to 64 New U.S. Patents In 2013 .................... 928

17.6.12 Jan 12, 2014: Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study

suggests 929

17.6.13 Jan 10, 2014: Macrocyclics introduces new products .......................................................................... 930

17.6.14 Jan 07, 2014: Beth Israel Deaconess Medical Center Uses Carestream‘s DRX Systems to Enhance

Diagnosis, Treatment of Critical Care Patients ..................................................................................................... 931

17.6.15 Jan 06, 2014: FDA Reclassifies ECP Devices for Refractory Angina as Class II ............................... 931

17.6.16 Dec 31, 2013: Immunomedics Announces U.S. Patent for Antibody-SN-38 Conjugates .................... 932

17.6.17 Dec 31, 2013: New MRI technique illuminates the wrist in motion ...................................................... 933

17.6.18 Dec 18, 2013: FLUIDDA Presents Novel Imaging Technology for Respiratory Diseases to FDA ...... 934

17.6.19 Dec 12, 2013: Insight Genetics Launches Insight Molecular Labs ...................................................... 934

17.6.20 Dec 09, 2013: Study suggests overdiagnosis in screening for lung cancer with low-dose CT ............ 935

17.6.21 Dec 04, 2013: Toshiba‘s New MR Technologies Make Exams Faster for Better Patient Care ........... 936

17.6.22 Dec 03, 2013: Carestream Health Unveils Latest X-ray Technology at World‘s Largest Radiology

Conference ............................................................................................................................................................ 936

17.6.23 Dec 02, 2013: Toshiba CT Delivers More Consistent Results with its Adaptive Diagnostics Technology

937

17.6.24 Dec 02, 2013: Toshiba Upgrades MR Interface for Streamlined Exams ............................................. 938




17.6.25 Dec 02, 2013: Orcasonix Unveils Innovative Ultrasound Technology Built on Cephasonics cQuest

Family of Ultrasound Systems ............................................................................................................................... 939

17.6.26 Dec 02, 2013: MRI Technique Reveals Low Brain Iron in ADHD Patients .......................................... 939

17.6.27 Dec 01, 2013: Viztek Debuts New PACS Platform at RSNA ............................................................... 940

17.6.28 Nov 27, 2013: IBA receives FDA clearance for its new Imaging Suite, a solid foundation for the

development of future Image-Guided Proton Therapy (IGPT) solutions ............................................................... 941

17.6.29 Nov 21, 2013: UCLA researchers' new technique improves accuracy, ease of cancer diagnosis ...... 941

17.6.30 Nov 19, 2013: A Better Patient Experience with Toshiba‘s Quiet MR Technology ............................. 942

17.6.31 Nov 19, 2013: New Imaging Tool Bypasses Blade to Check for Skin Cancer..................................... 943

17.6.32 Nov 18, 2013: Cephasonics Releases New cQuest Dragonfly Family of Ultra-Compact Ultrasound

Systems 943

17.6.33 Nov 14, 2013: Viztek to Significantly Improve Hospital-Referring Physician Communications With

Introduction of New EHR ....................................................................................................................................... 944

17.6.34 Nov 12, 2013: BioClinica Announces Innovative Big Data Research Project ...................................... 945

17.6.35 Oct 30, 2013: OneMedNet Launches BEAM Women‘s Health Image Exchange Service .................. 946

17.6.36 Oct 29, 2013: Lantheus Releases Preliminary Results from Phase 3 Clinical Trial of Flurpiridaz F 18

for the Detection of Coronary Artery Disease ........................................................................................................ 947

17.6.37 Oct 28, 2013: Sanovas Awarded Patent for Extravasated Drug Delivery ............................................ 948

17.6.38 Oct 28, 2013: Philips and RealView Imaging conclude world's first study to evaluate live 3D

holographic imaging in interventional cardiology ................................................................................................... 948

17.6.39 Oct 17, 2013: EOS imaging introduces breakthrough Micro Dose feature at JFR 2013 ..................... 949

17.6.40 Oct 07, 2013: MDxHealth‘s Prostate Cancer Test Meets Endpoints In DOCUMENT Trial ................. 950

17.6.41 Oct 04, 2013: BioTime Announces Development OF ReGlyde Based on HyStem Technology ......... 952

17.6.42 Oct 04, 2013: Test Demonstrates Effectiveness of Cancer Therapy in Children ................................ 953

17.6.43 Oct 02, 2013: Missouri Baptist Offers 3D Mammograms, Which Have Higher Cancer Detection Rates,

for Annual Breast Screenings ................................................................................................................................ 954

17.6.44 Oct 01, 2013: Ontario Switches to DR Mammography Based on Radiology Study ............................ 954

17.6.45 Sep 23, 2013: State of Florida Selects Magellan Complete Care to Launch Plan That Integrates

Behavioral/Physical Health Care in Eight Regions ................................................................................................ 955

17.6.46 Sep 19, 2013: Bruker Introduces New Multimodal Preclinical Imaging Animal Bed ............................ 956

17.6.47 Sep 18, 2013: Bruker Sets New Standards in Preclinical Imaging Software with ParaVision 6 .......... 956

17.6.48 Sep 02, 2013: Cancer Experts Detail New Approaches to Liver Cancer Treatment with Stereotactic

Ablative Radiotherapy ........................................................................................................................................... 957

17.6.49 Aug 30, 2013: Dako and Omnyx Launch Digital Pathology Solution for Breast Cancer Diagnostics .. 958

17.6.50 Aug 27, 2013: Air Techniques Announces the Integration of ScanX with Curve Dental‘s Cloud

Software 959

17.6.51 Aug 26, 2013: Agilent Technologies Launches Unique X-ray Detectors with Smart Sensitivity Control

960

17.6.52 Aug 22, 2013: Navidea Biopharmaceuticals Announces Agreement with FDA on Special Protocol

Assessments for NAV5001 Phase 3 Program ...................................................................................................... 960

17.6.53 Aug 21, 2013: Radioterapia Cabriales Now Offering Cancer Patients Fast, Precise Radiotherapy Using

Trilogy and RapidArc Technology from Varian Medical Systems ......................................................................... 961




17.6.54 Jul 30, 2013: Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo 962

17.6.55 Jul 23, 2013: New NIST Standard Reference Material to Help Calibrate Hospital CAT Scanners ..... 963

17.6.56 Jul 16, 2013: Bruker Announces New ECO Line of X-ray Diffraction (XRD) and X-ray Fluorescence

(XRF) Instruments ................................................................................................................................................. 964

17.6.57 Jun 27, 2013: VirtualScopics Completes Six Week Analysis Of Phase III Breast Cancer Study ........ 965

17.6.58 Jun 17, 2013: Philips‘s IMR Offers New Capabilities To Simultaneously Reduce CT Radiation And

Enhance Image Quality ......................................................................................................................................... 965

17.6.59 Jun 10, 2013: Toshiba Installs Aquilion One CT Scanner And Infinix-i Bi-Plane Cardiovascular X-Ray

At Summa Akron City Hospital .............................................................................................................................. 966

17.6.60 Jun 10, 2013: Agfa HealthCare Launches NX Musica2 Platinum And NX Musica2 Neonatal For Direct

Radiography In North America .............................................................................................................................. 967

17.6.61 May 23, 2013: Senior Scientific Announces Issuance Of US Patent For Detection, Measurement And

Imaging Of Cancer Cells Using Nanoparticles ...................................................................................................... 967

17.6.62 May 23, 2013: Hologic‘s US Study Shows 3D Mammography Significantly Reduces Recall Rates And

Improves Cancer Detection ................................................................................................................................... 968

17.6.63 May 09, 2013: NEC Display Solutions Obtains FDA 510(k) Clearance For MD211C2 And MD211C3

Medical Diagnostic Monitors .................................................................................................................................. 969

17.6.64 May 07, 2013: Royal Philips Electronics Launches Healthcare Transformation Services .................. 969

17.6.65 May 07, 2013: Toshiba To Introduce New EP Package At HRS Annual Meeting In Denver .............. 970

17.6.66 Apr 25, 2013: Carestream Ships More Than 6,000 Wireless DR Detectors ........................................ 970

17.6.67 Apr 22, 2013: BioClinica Announces Availability Of Express EDCplus ............................................... 971

17.6.68 Apr 16, 2013: Researchers Devise X-Ray Approach To Track Surgical Devices And Minimize

Radiation Exposure ............................................................................................................................................... 972

17.6.69 Apr 03, 2013: SonaCare Medical Launches Two New Products At EAU Congress In Italy ................ 972

17.6.70 Apr 03, 2013: Molecular Imaging Performs First Rubidium-82 Cardiac PET Scan In Delaware ......... 974

17.6.71 Apr 02, 2013: GE Healthcare Surpasses 500th Installation Of Mobile X-ray Platform In US .............. 974

17.6.72 Mar 13, 2013: Toshiba CT Enhances Patient Safety With MITA‘s Smart Dose Standard .................. 975

17.6.73 Mar 09, 2013: GE Healthcare Introduces New Products At ACC 2013 Conference ........................... 975

17.6.74 Mar 06, 2013: OiService CT & MR Receives Korean FDA Approval for Refurbished GE CT & MR

Equipment 976

17.7 Research And Development ........................................................................................................................ 977

17.7.1 Feb 10, 2014: ImaginAb and Duke-NUS Launch Imaging Biomarker Development Lab .................... 977

17.7.2 Oct 07, 2013: SpineGuard to Launch XS Classic PediGuard at North American Spine Society Annual

Meeting 978

17.7.3 Jun 04, 2013: Janssen-Cilag And National Taiwan University Enter Into Master Agreement To Co-

Develop Hepatitis B Treatments ............................................................................................................................ 979

17.7.4 May 30, 2013: Cook Medical Joins With Indiana Life Science Businesses, Academia And Government

To Help Launch Bioscience Research Center ...................................................................................................... 979

17.7.5 May 10, 2013: Canada‘s Sunnybrook Health Sciences Centre Joins Elekta And Philips Research

Consortium On MRI-Guided Radiation Therapy ................................................................................................... 980

17.7.6 Apr 20, 2013: Elekta And Philips Research Consortium On MRI-Guided Radiation Therapy Adds

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital ......................................................................... 981




17.8 Strategy And Business Planning .................................................................................................................. 982

17.8.1 Feb 20, 2014: Hu-Friedy and Electro Medical Systems Form Strategic Alliance ................................ 982

17.8.2 Feb 19, 2014: SonaCare Medical and NYU Langone Medical Center Collaborate to Advance New

Therapeutic Ultrasound Technology ...................................................................................................................... 983

17.8.3 Feb 04, 2014: BioClinica Grows eClinical Results In Europe .............................................................. 984

17.8.4 Jan 29, 2014: Bruker Opens New Preclinical Imaging Center of Excellence for the Americas ........... 985

17.8.5 Jan 28, 2014: Cancer Genetics Increases Access to Its Full-Suite of Cancer Diagnostic Services

Through Agreement With Three Rivers Provider Network .................................................................................... 986

17.8.6 Jan 21, 2014: Bayer HealthCare provides update on its business operations .................................... 986

17.8.7 Dec 17, 2013: Florida hospital unveils new and expanded emergency/trauma facility ....................... 986

17.8.8 Dec 11, 2013: Enzo Biochem and Flagship Biosciences Partner to Provide Tissue-Based Companion

Diagnostics Offering Complete Solution for In Situ Hybridization Development to Pharmaceutical Companies .. 987

17.8.9 Nov 25, 2013: Harlan Laboratories Announces Expansion of Imaging Services and Availability of

Disease-Validated Models at Israel Research Center ........................................................................................... 988

17.8.10 Nov 25, 2013: FluoroPharma Medical Is Elected to the Medical Imaging & Technology Alliance ...... 989

17.8.11 Nov 19, 2013: Sutter Health and Radiological Associates of Sacramento Join Forces ...................... 989

17.8.12 Nov 12, 2013: Philips and AMREF Flying Doctors announce strategic partnership to improve health

care in Africa .......................................................................................................................................................... 990

17.8.13 Oct 24, 2013: Viztek and Matakina Partner to Integrate Breast Density Assessment, Creating First

Complete RIS/PACS Breast Imaging Software Suite ............................................................................................ 991

17.8.14 Oct 03, 2013: MCPHS University and Esaote Open State-of-the-Art Diagnostic Medical Sonography

Lab in Worcester, Mass. ........................................................................................................................................ 992

17.8.15 Oct 01, 2013: Philips to shape the future of healthcare in Asia Pacific by bridging the Hospital and the

Home 993

17.8.16 Sep 26, 2013: Grand Opening of the Neuroimaging Center at Kessler Foundation ........................... 993

17.8.17 Sep 18, 2013: Sam Solakyan Successfully Expands Vital Imaging Across California ........................ 994

17.8.18 Sep 17, 2013: Groundbreaking Set For Minnetonka Medical Center .................................................. 996

17.8.19 Aug 30, 2013: IDS Cloud Technology Facilitates Diagnostic Imaging Group‘s Business Expansion . 996

17.8.20 Aug 19, 2013: Emory Healthcare and Alliance Imaging Open New Diagnostic Center in McDonough

997

17.8.21 Aug 05, 2013: Insight Genetics Adds Four .......................................................................................... 998

17.8.22 Aug 01, 2013: PerkinElmer Establishes Direct Operations in Israel .................................................... 998

17.8.23 Jul 01, 2013: Novel Device May Help Stop Leaky Heart Valves ......................................................... 999

17.8.24 Jun 27, 2013: Philips and Georgia Regents Medical Center sign a 15-year alliance to facilitate

innovative and affordable care ............................................................................................................................ 1000

17.8.25 Jun 20, 2013: Johnson & Johnson Innovation Opens Partnering Office In Stevenage Bioscience

Catalyst, UK ......................................................................................................................................................... 1001

17.8.26 Jun 03, 2013: Canon Establishes New Research Laboratory In Cambridge, US.............................. 1001

17.8.27 May 23, 2013: EOS imaging Expands In Singapore, Announces Sales Force Structure ................. 1001

17.8.28 May 23, 2013: HealthSouth Announces Plans To Build a Rehabilitation Hospital in Newnan, Georgia

1002

17.8.29 May 13, 2013: Analogic Announces Plan To Streamline Its Global Business ................................... 1003




17.8.30 May 06, 2013: Focused Ultrasound Foundation, Philips And InSightec Collaborate With Clinicians To

Launch Multicenter RELIEF Registry .................................................................................................................. 1003

17.8.31 May 02, 2013: Corgenix Expands Contract Services Business Unit ................................................. 1004

17.8.32 Mar 21, 2013: Lantheus Announces Corporate Plans ....................................................................... 1005

18 Appendix ......................................................................................................................................................... 1006

18.1 Research Methodology .............................................................................................................................. 1007

18.1.1 Coverage ............................................................................................................................................ 1007

18.1.2 Secondary Research .......................................................................................................................... 1007

18.1.3 Primary Research ............................................................................................................................... 1008

18.1.4 Market Modeling and Forecasting ...................................................................................................... 1009

18.1.5 Company Share Analysis ................................................................................................................... 1012

18.1.6 Distribution Share Analysis ................................................................................................................ 1014

18.2 Expert Panel ............................................................................................................................................... 1014

18.3 GlobalData Consulting ............................................................................................................................... 1014

18.5 Disclaimer ................................................................................................................................................... 1014




1.1 List of Tables

Table 1: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, 2005-2020 ................................................... 58

Table 2: Diagnostic Imaging Market, United States, Category Contribution by Revenue ($m), 2012 ............................................. 61

Table 3: Diagnostic Imaging Market, United States, Category Comparison by Revenue ($m), 2005-2020 ................................... 63

Table 4: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ..................................... 65

Table 5: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ................................... 67

Table 6: Diagnostic Imaging Market, United States, Volume (Units), 2005-2020 ........................................................................... 69

Table 7: Diagnostic Imaging Market, United States, Volume (Units), Historic, 2005-2012 ............................................................. 71

Table 8: Diagnostic Imaging Market, United States, Volume (Units), Forecast, 2012-2020 ........................................................... 73

Table 9: Diagnostic Imaging Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 .................... 75

Table 10: Angio Suites Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 .............................................. 76

Table 11: Angio Suites Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................................ 77

Table 12: Angio Suites Market, United States, Volume (Units), Historic, 2005-2012 ..................................................................... 78

Table 13: Angio Suites Market, United States, Volume (Units), Forecast, 2012-2020 ................................................................... 79

Table 14: Angio Suites Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ......................... 80

Table 15: Angio Suites Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 ............................ 82

Table 16: Bone Densitometers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ................................. 84

Table 17: Bone Densitometers Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................... 85

Table 18: Bone Densitometers Market, United States, Volume (Units), Historic, 2005-2012 ......................................................... 86

Table 19: Bone Densitometers Market, United States, Volume (Units), Forecast, 2012-2020 ....................................................... 87

Table 20: Bone Densitometers Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ............. 88

Table 21: Bone Densitometers Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 ................ 89

Table 22: C-Arms Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ...................................................... 90

Table 23: C-Arms Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .................................................... 91

Table 24: C-Arms Market, United States, Volume (Units), Historic, 2005-2012 ............................................................................. 92

Table 25: C-Arms Market, United States, Volume (Units), Forecast, 2012-2020 ........................................................................... 93

Table 26: C-Arms Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ................................. 94

Table 27: C-Arms Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 .................................... 96

Table 28: Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ............. 97

Table 29: Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ........... 98

Table 30: Computed Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 ..................................... 99

Table 31: Computed Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 ................................. 100

Table 32: Computed Tomography Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-

2012 ............................................................................................................................................................................................... 101

Table 33: Computed Tomography Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012

....................................................................................................................................................................................................... 103

Table 34: Contrast Media Injectors Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ......................... 104




Table 35: Contrast Media Injectors Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ....................... 105

Table 36: Contrast Media Injectors Market, United States, Volume (Units), Historic, 2005-2012 ................................................. 106

Table 37: Contrast Media Injectors Market, United States, Volume (Units), Forecast, 2012-2020 ............................................... 107

Table 38: Contrast Media Injectors Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ..... 108

Table 39: Contrast Media Injectors Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 ....... 109

Table 40: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Revenue ($m), USD

Constant, Historic, 2005-2012 ........................................................................................................................................................ 111

Table 41: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Revenue ($m), USD

Constant, Forecast, 2012-2020 ...................................................................................................................................................... 112

Table 42: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Volume (Units),

Historic, 2005-2012 ........................................................................................................................................................................ 114

Table 43: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Volume (Units),

Forecast, 2012-2020 ...................................................................................................................................................................... 116

Table 44: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Distribution Share by

Revenue ($m), USD Constant, 2011-2012 ..................................................................................................................................... 117

Table 45: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Company Share by

Revenue ($m), USD Constant, 2011-2012 ..................................................................................................................................... 119

Table 46: MRI Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 120

Table 47: MRI Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ........................................ 121

Table 48: MRI Systems Market, United States, Volume (Units), Historic, 2005-2012 .................................................................. 122

Table 49: MRI Systems Market, United States, Volume (Units), Forecast, 2012-2020 ................................................................ 123

Table 50: MRI Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ...................... 124

Table 51: MRI Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 ......................... 126

Table 52: Nuclear Imaging Equipment Market, United States, Segment Contribution (%), 2012 ................................................. 128

Table 53: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 .................... 130

Table 54: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .................. 132

Table 55: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2005-2012 ........................................... 134

Table 56: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2012-2020 ......................................... 136

Table 57: Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 137

Table 58: Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 .. 139

Table 59: Ultrasound Systems Market, United States, Segment Contribution (%), 2012 ............................................................. 141

Table 60: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 143

Table 61: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................. 145

Table 62: Ultrasound Systems Market, United States, Volume (Units), Historic, 2005-2012........................................................ 147

Table 63: Ultrasound Systems Market, United States, Volume (Units), Forecast, 2012-2020...................................................... 149

Table 64: Ultrasound Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ........... 150

Table 65: Ultrasound Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 .............. 152

Table 66: X-ray Systems Market, United States, Segment Contribution (%), 2012 ...................................................................... 154




Table 67: X-ray Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................ 156

Table 68: X-ray Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ...................................... 158

Table 69: X-ray Systems Market, United States, Volume (Units), Historic, 2005-2012 ................................................................ 160

Table 70: X-ray Systems Market, United States, Volume (Units), Forecast, 2012-2020 .............................................................. 162

Table 71: X-ray Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................... 163

Table 72: X-ray Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 ....................... 165

Table 73: Diagnostic Imaging Market Pipeline Products .............................................................................................................. 170

Table 74: Accellent To Acquire Lake Region Medical, Manufacturer Of Medical Devices ........................................................... 174

Table 75: Medovations Acquires Sandhill Scientific ..................................................................................................................... 176

Table 76: Globus Medical Acquires Excelsius Surgical, Medical Device Company ..................................................................... 177

Table 77: Channel Technologies Acquires H.C. Materials ........................................................................................................... 178

Table 78: Thorlabs Acquires CompuCyte, Laser Scanning Cytometry Products Provider ........................................................... 179

Table 79: Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics ................................................................. 180

Table 80: Analogic Acquires Remaining Majority Stake In PocketSonics, Ultrasound Technology Company, For Up To US$14

Million ............................................................................................................................................................................................. 181

Table 81: BC Technical Acquires C&G Technologies, Computed Tomography Solutions Provider ............................................. 182

Table 82: One Call Care Management Rumored To Sell Itself For Up To US$1.5 Billion ............................................................ 183

Table 83: Techne Completes Acquisition Of Bionostics For US$104 Million ................................................................................ 184

Table 84: Carl Zeiss Completes Acquisition Of Xradia ................................................................................................................. 186

Table 85: BC Technical Acquires Medx, Molecular Imaging Company ........................................................................................ 188

Table 86: Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million ..................................... 189

Table 87: BC Technical Acquires Nuclear Cardiology Systems, Provider Of Nuclear Medical Services ...................................... 191

Table 88: Analytik Jena To Acquire UVP, Digital Imaging Provider .............................................................................................. 192

Table 89: Solta Medical Completes Acquisition Of Sound Surgical For Up To US$40 Million ...................................................... 194

Table 90: Samsung Electronics America Acquires NeuroLogica, Medical Imaging Company ..................................................... 196

Table 91: Aris Teleradiology Acquires Pediatric Radiology of America ........................................................................................ 197

Table 92: GSI Group Acquires NDS Surgical Imaging For US$83 Million .................................................................................... 198

Table 93: RadNet Acquires Lenox Hill Radiology, Provider Of Diagnostic Imaging Services, For US$30 Million ........................ 200

Table 94: Claymount North America Acquires Advanced Instrument Development ..................................................................... 201

Table 95: BC Technical Completes Acquisition Of Genesis Medical Imaging .............................................................................. 202

Table 96: Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer ........... 203

Table 97: Endeavor Power Acquires Parallax Diagnostics, Bio-Medical Company ...................................................................... 204

Table 98: Solanbridge Group Acquires Advanced Medical Sales For US$0.2 Million .................................................................. 205

Table 99: KMH Labs Acquires Westcoast Radiology ................................................................................................................... 206

Table 100: Merit Medical Systems Acquires Medigroup, Maker Of Peritoneal Dialysis Catheters ............................................... 207

Table 101: Eczacibasi-Monrol Nukleer Urunler Completes Acquisition Of Capintec, Developer Of Nuclear Medicine Equipment

....................................................................................................................................................................................................... 208




Table 102: GE Healthcare Acquires U-Systems, Maker Of Breast Ultrasound Systems .............................................................. 209

Table 103: Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes ............................................................... 211

Table 104: Carestream Health Acquires Genesis Digital Imaging ................................................................................................ 212

Table 105: ITW Medical Acquires Coeur, Provider Of Medical Disposables ................................................................................ 214

Table 106: Siemens Healthcare To Acquire Penrith, Maker Of Ultrasound Imaging Systems ..................................................... 216

Table 107: Diagnostic Imaging International Completes Acquisition Of Schulkyll Open MRI For US$2.2 Million ......................... 217

Table 108: Accuray Acquires 90% Stake In Morphormics, Developer Of Medical Imaging Software, For US$6 Million .............. 218

Table 109: InSight Health Services Completes Acquisition Of Center for Diagnostic Imaging For US$91 Million ........................ 220

Table 110: BC Technical Acquires Xpert, Molecular Imaging Service Company ......................................................................... 222

Table 111: BC Technical Acquires Consus Medical Imaging, Molecular Imaging Equipment Service Provider ........................... 223

Table 112: BC Technical Acquires RA Services, Molecular Imaging Equipment Service Provider .............................................. 224

Table 113: RadNet Acquires West Coast Radiology For US$10 Million ....................................................................................... 225

Table 114: Dilon Technologies Acquires Navigator Gamma Probes From RMD Instruments ...................................................... 226

Table 115: Maven Biotechnologies Plans To Sell Label-Free Detection And Imaging Technology .............................................. 228

Table 116: Tristate Imaging Acquires 16 Diagnostic Imaging Centers ......................................................................................... 229

Table 117: Novadaq Technologies Acquires Surgical Marker Technology From TauTona .......................................................... 230

Table 118: Volcano To Acquire Pioneer Plus Re-Entry Catheter Product Line From Medtronic .................................................. 232

Table 119: Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For US$3 Million .................... 234

Table 120: GE Healthcare Acquires Transactional Business Of Unisyn Medical Technologies ................................................... 236

Table 121: Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions ................................. 238

Table 122: Threshold Pharma To Acquire Hypoxia PET Imaging Agent 18F-HX4 From Siemens Healthcare ............................ 240

Table 123: Northridge Trimodality Imaging Acquires Pre-Clinical Imaging Division Of Gamma Medica For US$2.5 Million ........ 242

Table 124: Fonar Acquires 14 MRI Scanning Centers For US$34.4 Million ................................................................................. 243

Table 125: Bruker To Acquire Preclinical In-Vivo Imaging Business From Carestream Health .................................................... 244

Table 126: Tranzbyte To Acquire Marketing Rights To MRI Machines In North And South America From Hurricane Enterprises

....................................................................................................................................................................................................... 246

Table 127: Acacia Research Acquires Patents For X-Ray Powder Diffraction Technology.......................................................... 247

Table 128: Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million ................................................... 248

Table 129: Idexx Labs Completes Private Placement Of Series B Notes Due 2025 For US$75 Million ....................................... 250

Table 130: Idexx Labs Completes Private Placement Of Series A Notes Due 2023 For US$75 Million ....................................... 251

Table 131: Johnson & Johnson Prices Public Offering Of Notes Due 2016 For US$400 Million .................................................. 252






Table 137: Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million ................................................ 264




Table 138: Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million ................................................ 266

Table 139: Accuray Completes Private Placement Of Notes Due 2018 For US$100 Million ........................................................ 268

Table 140: Computer Vision Systems Labs Announces Private Placement Of Notes For US$20 Million .................................... 270

Table 141: Diagnostic Imaging International Completes Private Placement Of Notes Due 2015 For US$2 Million ..................... 271

Table 142: Roper Industries Completes Public Offering Of Notes Due 2017 For US$400 Million ................................................ 272

Table 143: Roper Industries Completes Public Offering Of Notes Due 2022 For US$500 Million ................................................ 274

Table 144: Imaging3 Completes Private Placement Of Notes For US$0.3 Million ....................................................................... 276

Table 145: International Isotopes Completes Private Placement Of 8% Convertible Notes Due 2017 For US$3 Million ............. 277

Table 146: Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion .................................................. 279

Table 147: Radiation Therapy Services Completes Private Placement Of Notes Due 2017 For US$350 Million ......................... 280

Table 148: Merit Medical Systems Files Registration Statement For Public Offering Of Securities For US$200 Million .............. 282

Table 149: MicroVision Files Registration Statement For Public Offering Of Securities For US$25 Million.................................. 284

Table 150: Exosome Sciences Completes Private Placement Shares For US$1.1 Million .......................................................... 285

Table 151: Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million ................ 286

Table 152: Caliber Imaging & Diagnostics Announces Private Placement Of Common Stock..................................................... 287

Table 153: Cancer Genetic Announces Public Offering Of Common Stock For Up To US$50 Million ......................................... 288

Table 154: Navidea Biopharma Completes Private Placement Of Units For US$30 Million ......................................................... 290

Table 155: FluoroPharma Medical Completes First Tranche Of Private Placement Of Preferred Shares And Warrants For US$0.7

Million ............................................................................................................................................................................................. 292

Table 156: Enzo Biochem Files Shelf Registration Statement For Public Offering Of Securities For US$50 Million .................... 294

Table 157: Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million ................................................ 295

Table 158: Advanced Medical Isotope Completes Private Placement Of Shares And Warrants For US$0.3 Million ................... 297

Table 159: Enzo Biochem Announces Public Offering Of Common Stock For US$18 Million ...................................................... 298

Table 160: Advanced Medical Isotope Completes Private Placement Of Shares And Warrants For US$0.5 Million ................... 300

Table 161: Navidea Biopharma Completes Private Placement Of Shares For US$5 Million ....................................................... 301

Table 162: MRI Interventions Completes Private Placement Of Common Stock For US$11 Million ............................................ 303

Table 163: LipoScience Completes IPO For US$52 Million ......................................................................................................... 304

Table 164: Navidea Biopharma Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants ........... 306

Table 165: FluoroPharma Medical Completes First Tranche Of Private Placement Of Shares For US$2 Million ........................ 308

Table 166: Arrayit Diagnostics Announces Private Placement Of Shares For US$8 Million ........................................................ 309

Table 167: MRI Interventions Completes Private Placement Of Units For US$6 Million .............................................................. 310

Table 168: MicroVision Completes Public Offering Of Units For US$10.5 Million ........................................................................ 311

Table 169: MRI Interventions Completes IPO .............................................................................................................................. 313

Table 170: Advanced Medical Isotope Completes First Tranche Of Private Placement Of Units For US$0.05 Million ................ 314

Table 171: Imaging3 Announces Private Placement Of Common Stock For US$0.8 Million ....................................................... 315

Table 172: MicroVision Completes Private Placement Of Shares For US$5 Million .................................................................... 316

Table 173: ProUroCare Medical Completes Private Placement Of Shares For US$0.43 Million .................................................. 317




Table 174: VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million ..................................... 318

Table 175: MSC Care Management Completes Merger With One Call Medical .......................................................................... 319

Table 176: Tornado Medical Systems Completes Merger With Arjae Spectral Enterprises ......................................................... 321

Table 177: MRI Interventions Enters Into Co-Development Agreement With Siemens Medical Solutions ................................... 322

Table 178: MRI Interventions Terminates Co-Development Agreement With Siemens Healthcare ............................................. 324

Table 179: Fovia Enters Into Co-Development Agreement With Visual Medica ........................................................................... 325

Table 180: CorTechs Labs Extends Distribution Agreement With Invivo For NeuroQuant ........................................................... 326

Table 181: P-Cure Enters Into Development Agreement With Philips Healthcare ....................................................................... 327

Table 182: Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner ........................................................... 328

Table 183: RaySearch Labs Terminates Licensing Agreement With TomoTherapy .................................................................... 329

Table 184: RadioMedix Enters Into Distribution Agreement With ITG Isotope Technologies ....................................................... 330

Table 185: Siemens Healthcare Enters Into Co-Development Agreement With Pfizer ................................................................ 331

Table 186: Bracco Imaging Enters Into Co-Marketing Agreement With PHS Technologies For DoseMonitor ............................. 333

Table 187: Imaging Dynamics To Enter Into Co-Marketing Agreement With Kangda Medical ..................................................... 334

Table 188: VuCOMP Enters Into Agreement With Konica Minolta ............................................................................................... 335

Table 189: KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies ... 336

Table 190: IMRIS Enters Into Technology Integration Agreement With Stryker ........................................................................... 337

Table 191: Positron Enters Into Licensing Agreement With Institute for Nuclear Research For Radiostrontium Production

Technology ..................................................................................................................................................................................... 338

Table 192: Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics ............................................ 340

Table 193: Carestream Enters Into Co-Development Agreement With Buffalo Bills .................................................................... 341

Table 194: Bluechiip Enters Into Distribution Agreement With Mitegen ....................................................................................... 343

Table 195: GE Healthcare And Konica Minolta Enter Into Global Distribution Agreement For AeroDR ....................................... 344

Table 196: Sonomed Escalon Enters Into Technology Integration Agreement With First Insight ................................................. 345

Table 197: Radialogica Enters Into Licensing Agreement With Philips Healthcare ...................................................................... 346

Table 198: Daylight Solutions Enters Into Licensing Agreement With Corning ............................................................................ 347

Table 199: Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform ...................................... 348

Table 200: Electrical Geodesics Enters Into Distribution Agreement With Hitachi Medical Systems America ............................. 350

Table 201: MiTeGen Enters Into Development And Distribution Agreement With EMBL Enterprise ............................................ 351

Table 202: Icahn School of Medicine at Mount Sinai Enters Into Co-Development Agreement With Rensselaer Polytechnic

Institute For Diagnostic Tools ......................................................................................................................................................... 352

Table 203: Positron And Biologics Modular Enter Into Co-Marketing Agreement For PosiRx System ......................................... 354

Table 204: UltraSPECT Enters Into Distribution Agreement With PharmaLogic .......................................................................... 355

Table 205: SonaCare Medical Enters Into Integration Agreement With UCL Business For Prostate Cancer Treatment System 356

Table 206: Toshiba Enters Into Agreement With Shands HealthCare And Keck Medical Center For MR Research ................... 358

Table 207: Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters ......... 359

Table 208: Advanced Medical Isotope Enters Into Co-Development Agreement With GSG International ................................... 360




Table 209: Invivo Enters Into Co-Development Agreement With iCAD For MRI Solutions........................................................... 361

Table 210: Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System ....... 362

Table 211: Philips Enters Into Technology Integration Agreement With Biosense Webster ......................................................... 363

Table 212: Bluechiip Enters Into Licensing Agreement With Mitegen For Cryopins ..................................................................... 364

Table 213: ImaginAb Exercises Option For Licensing Agreement With Oxford BioMedica To License Vivo 5T4-Based Imaging

Diagnostic ....................................................................................................................................................................................... 365

Table 214: GE Healthcare Enters Into Licensing Agreement With University of Wisconsin For CT Scan Protocols .................... 366

Table 215: GE Healthcare Enters Into Agreement With Core Sound Imaging To Distribute Studycast ....................................... 367

Table 216: Optimal Radiology Forms Joint Venture With Advanced Diagnostic Imaging ............................................................. 368

Table 217: Imorgon Enters Into Technology Integration Agreement With TomTec Imaging Systems .......................................... 369

Table 218: Canon Enters Into Co-Development Agreement With Massachusetts General Hospital And Brigham and Women‘s

Hospital .......................................................................................................................................................................................... 370

Table 219: Siemens Enters Into Co-Development Agreement With Varian Medical For Imaging Products ................................. 372

Table 220: NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents ........................... 374

Table 221: Imorgon Enters Into Integration Agreement With Clickview ........................................................................................ 375

Table 222: NeoChord Enters Into Licensing Agreement With Robarts Research Institute ........................................................... 376

Table 223: Bioventus Enters Into Agreement With Esaote North America For Diagnostic Ultrasound And MRI Solutions .......... 377

Table 224: Alliance Healthcare Partners With Emory Healthcare For Diagnostic Imaging Facility ............................................... 378

Table 225: GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics

....................................................................................................................................................................................................... 379

Table 226: Carestream Health Enters Into Co-Development Agreement With Rutgers University ............................................... 381

Table 227: IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben ................................. 382

Table 228: Molecular Targeting Technologies Enters Into Licensing Agreement With Medical College of Wisconsin For 99mTc-

HYNIC-Duramycin .......................................................................................................................................................................... 383

Table 229: Intermountain Healthcare Enters Into Agreement With GE Healthcare ...................................................................... 384

Table 230: ActiViews Enters Into Agreement With NeuroLogica To Develop Surgical Navigation System .................................. 386

Table 231: Vascular Solutions Enters Into Distribution Agreement With VueTek Scientific For Veinsite ..................................... 387

Table 232: Sectra Enters Into Distribution Agreement With Mammography Reporting System For MRS7 Integrated With Breast

Imaging PACS ................................................................................................................................................................................ 388

Table 233: Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid ........................................................ 389

Table 234: M*Modal Enters Into Technology Integration Agreement With DataPhysics Research .............................................. 390

Table 235: Accuray Enters Into Co-Development Agreement With German Cancer Research Center ....................................... 391

Table 236: Carestream Health Enters Into Co-Development Agreement With Beatson Institute for Cancer Research ............... 392

Table 237: Royal Philips Enters Into Co-Development Agreement With St. Joseph‘s Hospital .................................................... 393

Table 238: Varian Medical Systems Enters Into Co-Marketing Agreement With Siemens Healthcare ......................................... 394

Table 239: Abbott Vascular Enters Into Co-Marketing Agreement With St. Jude Medical ........................................................... 396

Table 240: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System

....................................................................................................................................................................................................... 398




Table 241: Ground Fluor Pharma Enters Into Licensing Agreement With NUtech Ventures ........................................................ 399

Table 242: Aspect Imaging Enters Into Agreement With Bruker For MRI Systems ...................................................................... 400

Table 243: TPG Capital And Fosun Pharma To Acquire Chindex International For US$369 Million ............................................ 402

Table 244: Salt Creek Capital Acquires Ultra Solutions ............................................................................................................... 404

Table 245: Onex Reportedly Calls Off Auction Of Carestream Health For US$3.5 Billion ........................................................... 405

Table 246: Psilos Acquires Clinical Imaging Division Of Gamma Medica For US$3.1 Million ...................................................... 407

Table 247: JLL Partners Completes Acquisition Of BioClinica, Provider Of Clinical Trial Management Solutions, For US$123

Million ............................................................................................................................................................................................. 408

Table 248: Shore Capital Invests In Fast Pace Urgent Care ........................................................................................................ 410

Table 249: Cephasonics Acquires Ultrasound Business Unit From Samplify Systems ................................................................ 411

Table 250: Bruin Biometrics Raises US$10 Million In Venture Financing .................................................................................... 412

Table 251: Seno Medical Instruments Raises US$26 Million In Extended Series C Financing .................................................... 413

Table 252: Burl Concepts To Raise US$2 Million In Venture Financing ....................................................................................... 414

Table 253: Evena Medical Raises US$5 Million In Series B Financing ........................................................................................ 415

Table 254: DxNow Raises Funds Through Seed Financing ......................................................................................................... 416

Table 255: Dilon Technologies Raises US$4 Million In Venture Financing .................................................................................. 417

Table 256: ViewRay Raises US$30 Million In Venture Financing ................................................................................................ 418

Table 257: Blaze Bioscience Raises US$9 Million In Series B Financing .................................................................................... 420

Table 258: Veran Medical Raises US$3 Million In Venture Financing .......................................................................................... 421

Table 259: ViewRay Raises US$15 Million In Venture Financing ................................................................................................ 422

Table 260: Cerevast Therapeutics Raises US$1.8 Million In Venture Financing .......................................................................... 423

Table 261: Phi Optics Raises US$0.25 Million In Seed Financing ............................................................................................... 424

Table 262: TechDevice Raises Funds Through Venture Financing ............................................................................................. 425

Table 263: EchoPixel Raises US$2.35 Million In Seed Financing ................................................................................................ 426

Table 264: Sabik Medical Raises US$0.8 Million In Venture Financing ....................................................................................... 427

Table 265: Monteris Medical Raises US$8.3 Million In Venture Financing................................................................................... 428

Table 266: Sofie Biosciences Raises US$5 Million In Series A Financing Round ........................................................................ 430

Table 267: BioNano Genomics Raises US$10 Million In Venture Financing ................................................................................ 431

Table 268: KeyMed Imaging To Raise US$2 Million In Venture Financing .................................................................................. 433

Table 269: Delphinus Medical Technologies Raises US$11 Million In Series B Financing .......................................................... 434

Table 270: Traycer Diagnostic Systems Raises US$2.8 Million In Venture Financing ................................................................. 435

Table 271: CorTechs Labs Raises US$2 Million In Venture Financing ........................................................................................ 436

Table 272: Gamma Medica Raises US$16 Million Series A Financing ........................................................................................ 437

Table 273: Lantos Technologies Raises US$5.1 Million In Venture Financing ............................................................................. 438

Table 274: Mirabilis Medica Raises US$4 Million In Series A-1 Financing ................................................................................... 439

Table 275: Clear Guide Medical To Raise US$0.5 Million In Venture Financing .......................................................................... 440

Table 276: Mobisante Raises US$4 Million In Series A Venture Financing .................................................................................. 441




Table 277: Sonivate Medical Raises US$0.13 Million In Venture Financing ................................................................................ 442

Table 278: Sonivate Medical Raises US$0.8 Million In Venture Financing .................................................................................. 443


Table 280: Clear Vascular Raises US$0.3 Million In Venture Financing ...................................................................................... 445

Table 281: Active Life Scientific Raises US$0.5 Million In Series A Financing ............................................................................. 446

Table 282: Ninepoint Medical Plans To Raise US$35 Million In Series B Financing .................................................................... 447

Table 283: ViewRay Raises US$15 Million In Series D-2 Financing ............................................................................................ 448

Table 284: OraMetrix Raises US$0.2 Million In Venture Financing .............................................................................................. 449

Table 285: Companion Diagnostics To Raise US$1 Million In Venture Financing ....................................................................... 450

Table 286: Epic Research & Diagnostics Raises US$1.4 Million In Venture Financing ............................................................... 451

Table 287: Cerevast Therapeutics Raises US$1.5 Million In Venture Financing .......................................................................... 452

Table 288: dBMEDx Raises US$1.1 Million In Second Round Of Financing ................................................................................ 453

Table 289: Integrated Biometrics Raises US$0.44 Million In Venture Financing .......................................................................... 454

Table 290: Intrinsic Medical Imaging To Raise US$15 Million In Venture Financing .................................................................... 455

Table 291: Mirabilis Medica Raises US$0.5 Million In Venture Financing .................................................................................... 456

Table 292: Strategic Polymer Sciences Raises US$6.6 Million In Series B Financing ................................................................. 457

Table 293: CVUS Clinical Trials To Raise US$7.5 Million In Venture Financing .......................................................................... 458

Table 294: Mirabilis Medica Raises US$0.06 Million In Venture Financing .................................................................................. 459

Table 295: Hubble Telemedical Raises US$0.3 Million In Venture Financing .............................................................................. 460

Table 296: Ortho Kinematics Raises More Than US$2 Million In Series B Financing .................................................................. 461

Table 297: Integrated Biometrics Raises US$0.17 Million In Venture Financing .......................................................................... 462

Table 298: Avelas Biosciences Raises US$7.7 Million In Series A Financing .............................................................................. 463

Table 299: Precision Through Imaging Raises US$0.13 Million In Venture Financing ................................................................. 464

Table 300: Naviscan Raises US$1 Million In Venture Financing .................................................................................................. 465

Table 301: ViewRay Raises US$11 Million In Series D-1 Financing ............................................................................................ 466

Table 302: Applied BioCode Raises US$7 Million In Series A Financing ..................................................................................... 467

Table 303: Imanin To Raise US$0.025 Million In Seed Financing ................................................................................................ 468

Table 304: Epic Research Raises US$0.8 Million In Venture Financing ...................................................................................... 469

Table 305: ZetrOZ Raises US$4.5 Million In Venture Financing .................................................................................................. 470

Table 306: PartTec Raises US$0.6 Million In Venture Financing ................................................................................................. 471

Table 307: Serene Oncology Raises US$0.3 Million In Venture Financing .................................................................................. 472

Table 308: SR One Plans To Invest In Biotechnology Company ................................................................................................. 473

Table 309: Quantason Raises US$3.2 Million In Series B Financing ........................................................................................... 474

Table 310: Oncoscope Raises US$0.45 Million In Venture Financing ......................................................................................... 475

Table 311: Dbmedx Raises Funds Through Seed Financing Round ............................................................................................ 476

Table 312: Traycer Diagnostic Systems Raises US$0.5 Million In Venture Financing ................................................................. 477

Table 313: ABT Molecular Imaging Raises US$6 Million In Series C Financing .......................................................................... 478




Table 314: NorthStar Medical Technologies Raises US$5 Million In Series D Financing ............................................................ 480

Table 315: Tribogenics Raises Additional US$4.2 Million In Series A Financing ......................................................................... 481

Table 316: Raydiance Raises US$20 Million In Venture Financing .............................................................................................. 482

Table 317: ABT Molecular Imaging Raises US$0.2 Million In Venture Financing ........................................................................ 484

Table 318: First Warning Systems Raises US$1 Million In Series A Financing ............................................................................ 485

Table 319: Foundation Radiology Raises US$0.5 Million In Venture Financing ........................................................................... 486

Table 320: Lucidux Raises US$0.25 Million In Seed Financing Round ........................................................................................ 487

Table 321: Marval Biosciences Raises US$2.5 Million In Venture Financing ............................................................................... 488

Table 322: Ikonisys Raises US$0.1 Million In Venture Financing ................................................................................................. 489

Table 323: Iheart Raises US$1.1 Million In Venture Financing .................................................................................................... 490

Table 324: Diagnostic Photonics Raises US$0.41 Million In Venture Financing .......................................................................... 491

Table 325: BioNano Genomics Raises US$10 Million In Series B-1 Financing ............................................................................ 492


Table 327: BioNano Genomics Raises US$8.8 Million In Venture Financing ............................................................................... 495

Table 328: U-Systems Raises US$5 Million In Venture Financing ............................................................................................... 496

Table 329: U-Systems Raises US$3 Million In Venture Financing ............................................................................................... 497

Table 330: Blaze Bioscience Raises US$8.5 Million In Series A Financing ................................................................................. 498

Table 331: Signa MRI Imaging To Raise US$0.05 Million In Venture Financing .......................................................................... 499

Table 332: Penrith Raises US$1.5 Million In Venture Financing .................................................................................................. 500

Table 333: Monteris Medical Raises US$17 Million In Series D Financing .................................................................................. 501

Table 334: Foundation Radiology Raises Additional US$0.04 Million In Venture Financing ........................................................ 503

Table 335: ImaginAb Raises US$12.5 Million In Series A Financing ........................................................................................... 504

Table 336: Microlytic Raises US$3.5 Million In Venture Financing ............................................................................................... 506

Table 337: ViewRay, Medical Device Company Raises US$45 Million In Series C Financing ..................................................... 507

Table 338: Seno Medical Instruments Raises Additional US$7 Million In Series C Financing ..................................................... 509

Table 339: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country ..................... 1009

1.2 List of Figures

Figure 1: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, 2005-2020 .................................................. 57

Figure 2: Diagnostic Imaging Market, United States, Revenue Mix ($m), 2012 ............................................................................. 59

Figure 3: Diagnostic Imaging Market, United States, Category Contribution (%), 2012 ................................................................. 60

Figure 4: Diagnostic Imaging Market, United States, Category Comparison by Revenue ($m), 2005-2020 .................................. 62

Figure 5: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 .................................... 64

Figure 6: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .................................. 66

Figure 7: Diagnostic Imaging Market, United States, Volume (Units), 2005-2020 .......................................................................... 68

Figure 8: Diagnostic Imaging Market, United States, Volume (Units), Historic, 2005-2012 ............................................................ 70

Figure 9: Diagnostic Imaging Market, United States, Volume (Units), Forecast, 2012-2020 .......................................................... 72




Figure 10: Diagnostic Imaging Market, United States, Company Share (%), 2012 ........................................................................ 74

Figure 11: Angio Suites Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ............................................ 76

Figure 12: Angio Suites Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .......................................... 77

Figure 13: Angio Suites Market, United States, Volume (Units), Historic, 2005-2012 .................................................................... 78

Figure 14: Angio Suites Market, United States, Volume (Units), Forecast, 2012-2020 .................................................................. 79

Figure 15: Angio Suites Market, United States, Company Share (%), 2012................................................................................... 81

Figure 16: Bone Densitometers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 83

Figure 17: Bone Densitometers Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................. 85

Figure 18: Bone Densitometers Market, United States, Volume (Units), Historic, 2005-2012 ........................................................ 86

Figure 19: Bone Densitometers Market, United States, Volume (Units), Forecast, 2012-2020 ...................................................... 87

Figure 20: Bone Densitometers Market, United States, Company Share (%), 2012 ...................................................................... 89

Figure 21: C-Arms Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 .................................................... 90

Figure 22: C-Arms Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .................................................. 91

Figure 23: C-Arms Market, United States, Volume (Units), Historic, 2005-2012 ............................................................................ 92

Figure 24: C-Arms Market, United States, Volume (Units), Forecast, 2012-2020 .......................................................................... 93

Figure 25: C-Arms Market, United States, Company Share (%), 2012 .......................................................................................... 95

Figure 26: Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ............ 97

Figure 27: Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .......... 98

Figure 28: Computed Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 .................................... 99

Figure 29: Computed Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 ................................ 100

Figure 30: Computed Tomography Systems Market, United States, Company Share (%), 2012 ................................................ 102

Figure 31: Contrast Media Injectors Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ........................ 104

Figure 32: Contrast Media Injectors Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ...................... 105

Figure 33: Contrast Media Injectors Market, United States, Volume (Units), Historic, 2005-2012 ................................................ 106

Figure 34: Contrast Media Injectors Market, United States, Volume (Units), Forecast, 2012-2020 .............................................. 107

Figure 35: Contrast Media Injectors Market, United States, Company Share (%), 2012 .............................................................. 109

Figure 36: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Revenue ($m), USD

Constant, Historic, 2005-2012 ........................................................................................................................................................ 110

Figure 37: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Revenue ($m), USD

Constant, Forecast, 2012-2020 ...................................................................................................................................................... 112

Figure 38: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Volume (Units),

Historic, 2005-2012 ........................................................................................................................................................................ 113

Figure 39: Mammography Equipment (Full-Field Digital Mammography Equipment) Market, United States, Volume (Units),

Forecast, 2012-2020 ...................................................................................................................................................................... 115

Figure 40: Mammography Equipment Market, United States, Company Share (%) 2012 ............................................................ 118

Figure 41: MRI Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ......................................... 120

Figure 42: MRI Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ....................................... 121




Figure 43: MRI Systems Market, United States, Volume (Units), Historic, 2005-2012 ................................................................. 122

Figure 44: MRI Systems Market, United States, Volume (Units), Forecast, 2012-2020 ............................................................... 123

Figure 45: MRI Systems Market, United States, Company Share (%), 2012 ............................................................................... 125

Figure 46: Nuclear Imaging Equipment Market, United States, Revenue Mix ($m), 2012 ............................................................ 127

Figure 47: Nuclear Imaging Equipment Market, United States, Segment Contribution (%), 2012 ................................................ 128

Figure 48: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 .................. 129

Figure 49: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ................ 131

Figure 50: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2005-2012 .......................................... 133

Figure 51: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2012-2020 ........................................ 135

Figure 52: Nuclear Imaging Equipment Market, United States, Company Share (%), 2012......................................................... 138

Figure 53: Ultrasound Systems Market, United States, Revenue Mix ($m), 2012 ........................................................................ 140

Figure 54: Ultrasound Systems Market, United States, Segment Contribution (%), 2012 ............................................................ 141

Figure 55: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012............................... 142

Figure 56: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020............................. 144

Figure 57: Ultrasound Systems Market, United States, Volume (Units), Historic, 2005-2012 ...................................................... 146

Figure 58: Ultrasound Systems Market, United States, Volume (Units), Forecast, 2012-2020 .................................................... 148

Figure 59: Ultrasound Systems Market, United States, Company Share (%), 2012 ..................................................................... 151

Figure 60: X-ray Systems Market, United States, Revenue Mix ($m), 2012 ................................................................................. 153

Figure 61: X-ray Systems Market, United States, Segment Contribution (%), 2012 ..................................................................... 154

Figure 62: X-ray Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ....................................... 155

Figure 63: X-ray Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ..................................... 157

Figure 64: X-ray Systems Market, United States, Volume (Units), Historic, 2005-2012 ............................................................... 159

Figure 65: X-ray Systems Market, United States, Volume (Units), Forecast, 2012-2020 ............................................................. 161

Figure 66: X-ray Systems Market, United States, Company Share (%), 2012 ............................................................................. 164

Figure 67: GlobalData Epidemiology-Based Forecasting Model ................................................................................................ 1011

Figure 68: GlobalData Capital Equipment-Based Forecasting Model ........................................................................................ 1012

Figure 69: Primary Interviews by Participant Type (%) ............................................................................................................... 1013




2 Introduction

Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms

of revenues, unit sales, distributors and competitors

2.1 What Is This Report About?

This report provides an overview and the following information related to the country, various categories, distribution

share and competitive landscape in the market:

1. Comprehensive data related to the market revenue, unit sale, average price, company share and

distribution share.

2. Corporate-level profiles of key companies operating in the Diagnostic Imaging market, which includes a

brief overview of the company. The selection of the companies is based on their operational presence.

3. A list of key products under development by different companies. The selection of this list is based on the

territory in which these products are being clinically investigated.

4. Key news and deals related to the Diagnostic Imaging market.

2.2 Diagnostic Imaging Market Segmentation

Diagnostic Imaging market is segmented into the following categories, as described below, in this report:

1. Angio Suites

2. Bone Densitometers

3. C-Arms

4. Computed Tomography (CT) Systems includes segments such as

High Slice CT Systems

Low Slice CT Systems

Mid Slice CT Systems

5. Contrast Media Injectors includes segments such as

CT Injectors

Interventional Cardiology/Angio Injectors

MRI Injectors

6. Mammography Equipment includes segments such as

Film-Screen Mammography Equipment

Full-Field Digital Mammography Equipment

• Full-Field Digital Mammography Equipment includes sub-segments such as 2D Digital

Mammography Equipment and 3D Tomosynthesis

7. Magnetic Resonance Imaging (MRI) Systems includes segments such as

High Field MRI Systems




Low Field MRI Systems

Mid Field MRI Systems

8. Nuclear Imaging Equipment includes segments such as

Positron Emission Tomography (PET) Systems

• Positron Emission Tomography Systems includes sub-segments such as PET Systems, PET/CT

and PET/MRI Systems

Single Photon Emission Computed Tomography (SPECT) Systems

• Single Photon Emission Computed Tomography Systems includes sub-segments such as SPECT

and SPECT/CT Systems

9. Ultrasound Systems includes segments such as

B/W Ultrasound Systems

• B/W Ultrasound Systems includes sub-segments such as Portable B/W Ultrasound Systems and

Stand Alone B/W Ultrasound Systems

Color Ultrasound Systems

• Color Ultrasound Systems includes sub-segments such as Portable Color Ultrasound Systems and

Stand Alone Color Ultrasound Systems

10. X-ray Systems includes segments such as

Analog X-ray Systems

Digital X-ray Systems

• Digital X-ray Systems includes sub-segments such as Computed Radiography (CR) Systems and

Digital Radiography (DR) Systems

Retrofit X-ray Systems




Page 57

3 Diagnostic Imaging Market, United States

3.1 Diagnostic Imaging Market, United States, Revenue ($m), 2005-2020

Figure 1: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, 2005-2020

Source: GlobalData




Page 58

Table 1: Diagnostic Imaging Market, United States, Revenue ($m), USD Constant, 2005-2020

Category 2005 2012 2020 CAGR 05-12 CAGR 12-20 CAGR 05-20

Source: GlobalData




Page 59

3.2 Diagnostic Imaging Market, United States, Revenue Mix ($m), 2012

Figure 2: Diagnostic Imaging Market, United States, Revenue Mix ($m), 2012

Source: GlobalData




Page 60

3.3 Diagnostic Imaging Market, United States, Category Contribution by Revenue ($m), 2012

Figure 3: Diagnostic Imaging Market, United States, Category Contribution (%), 2012

Source: GlobalData




Page 61

Table 2: Diagnostic Imaging Market, United States, Category Contribution by Revenue ($m), 2012

Category Revenue ($m) Contribution Revenue (%) Contribution

Source: GlobalData




Page 1006

18 Appendix

The data and analysis within this report are driven by Medical eTrack. Medical eTrack gives you the key information

required to drive sales, investment and deal-making activity in your business. It includes the following:

15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries,

from 2005 and forecast to 2020

6,000+ primary expert interviews, conducted annually to ensure data and report quality

1,100+ medical equipment conference reports

1,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities

and competitive landscape

600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends

and issues, and investment and M&A trends worth over $3m

50,000+ medical equipment company profiles

2,000+ private, emerging and technology start-up company profiles

4,000+ company profiles of medical equipment manufacturers in China and India

2,000+ company profiles of medical equipment manufacturers in Japan

825+ companies‘ revenue splits and market shares

1,100+ quarterly and annual medical equipment company financials

700+ medical equipment company SWOTs

11,700+ pipeline product profiles

14,000+ marketed product profiles

16,900+ clinical trials

17,000+ trial investigators

18,000+ new product patents

3,700+ reports on companies with products in development

21,500+ reports on deals in the medical equipment industry

1,300+ surgical and diagnostic procedures by therapy area

50+ key healthcare indicators by country




Page 1007

For more information or to receive a free demonstration of the service, please visit:

http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo

18.1 Research Methodology

GlobalData‘s dedicated research and analysis teams consist of experienced professionals with advanced statistical

expertise and marketing, market research and consulting backgrounds in the medical devices industry.

GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Research Association

(http://www.ephmra.org/).

All GlobalData databases are continuously updated and revised.

18.1.1 Coverage

The objective of updating GlobalData‘s coverage is to ensure that it represents the most up-to-date vision of the

industry possible.

Changes to the industry taxonomy are built on the basis of extensive research of company, association and

competitor sources.

Company coverage is based on three key factors: revenue; product and media attention; and innovation and market

potential.

The estimated revenue of all major companies, both private and public, are gathered and used to prioritize coverage.

GlobalData aims to cover all major news events and deals in the medical devices industry, updated on a daily basis.

The coverage is further streamlined and strengthened with additional input from GlobalData‘s expert panel.

18.1.2 Secondary Research

The research process begins with extensive secondary research using internal and external sources to gather all

relevant data and information pertaining to a particular market model for a particular country. The secondary research

sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings

Industry trade journals, scientific journals and other technical literature

Association and healthcare organization websites

PubMed, Medscape and other relevant services which compile extensive reviews of clinical literature

Internal proprietary databases




Page 1008

Relevant patent and regulatory databases

National government documents, statistical databases and market reports

Procedure registries

News articles, press releases and web-casts specific to the companies operating in the market

18.1.3 Primary Research

GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis.

A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape and

future outlook

Helps to validate and strengthen secondary research findings

Further develops the analysis team‘s expertise and market understanding

Primary research involves email correspondence, telephone interviews and face-to-face interviews for each market,

category, segment and sub-segment across a range of geographies.

The participants who typically take part in such a process include, but are not limited to:

o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and

national sales managers

o Distributors, paramedics and representatives from hospital stores, laboratories and pharmacies

o Outside experts: investment bankers, valuation experts and research analysts that specialize in specific

medical equipment markets

o Key opinion leaders: physicians and surgeons that specialize in the therapeutic areas in which the

medical device is used

The following table lists the total number of primary research participants by country, in this case for the diagnostic

imaging equipment market. Market data is validated using inputs from 895 primary research participants. These

include demand-side stakeholders such as radiologists, and supply-side participants such as marketing managers,

sales managers and product managers of companies manufacturing/marketing diagnostic imaging equipment.




Page 1009

Table 339: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country

Country Total number of primary research participants

US 149

UK 112

Germany 79

France 54

Italy 40

Spain 53

Brazil 30

China 21

India 76

Russia 33

Japan 31

Australia 61

Canada 71

Mexico 43

South Korea 42

Total 895

Source: GlobalData

18.1.4 Market Modeling and Forecasting

GlobalData uses an epidemiology-based treatment flow model and capital equipment-based model to estimate and

forecast market size.

Epidemiology-Based Market Model and Forecasting

The epidemiology-based forecasting model uses epidemiology data gathered from research publications and primary

interviews with physicians to establish the target patient population and treatment flow pattern for individual diseases

and therapies. The data covers prevalence, incidence, diseased population, diagnosed population, and treatment

population.

The market forecast begins with the general population, the size of which varies depending on the indication.

Prevalence is the percentage of the total population that suffers from a particular disease or condition.




Page 1010

Incidence is the number of new cases of a condition, symptom, death or injury that develop during a specific

time period, such as one year.

The diseased population is the population suffering from a particular disease or condition.

The diagnosed population is the population that has been diagnosed with a particular disease or condition,

expressed as a percentage of the prevalence population.

The treatment population is the percentage of the population that has been diagnosed with a particular

disease or condition.

Device uptake is the percentage of the treatment population using a particular device, determined based on

the primary responses and the information available in secondary sources.

The epidemiology-based forecasting model for a medical device is used to:

Determine the patient segment using a particular device or procedure

Determine the frequency of usage of a particular device depending on the patient type, which further helps to

determine the absolute unit sales of a device in a year

The market for any medical device is directly proportional to the volume of units sold and the price per unit.

Market size = volumes of units sold X ASP (Average Selling Price)

The volume of units sold is calculated from the number of patients using or that has been implanted with the device.

Data on treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, is gathered

from interviews with physicians and used to estimate the patient volume for the disease under consideration.

The ASP of a device is mostly gathered from primary and secondary sources. ASP is the price at which a device is

available in a target country to an end-user. For capital equipment, the end-user is typically considered to be the

healthcare setting. For implants and consumables purchased by patients, the end-user is the patient.

Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into

consideration during ASP analysis, which uses the following sources:

Company websites

Annual reports/industry reports

Press releases




Page 1011

Epidemiology-Based Forecasting Model

Capital Equipment-Based Market Model and Forecasting

The capital equipment-based forecasting model is based on the installed base, replacements and new sales of a

specific type of capital equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. The

installed base is calculated from the average number of units per facility. Sales for a particular year are arrived at by

calculating the number of replacement units and new units (additional and first-time purchases). Secondary sources

and interviews with supply-side participants and key opinion leaders from healthcare facilities are used to arrive at

installed base and unit sales for a particular year. The factors typically affecting the forecast growth rates are:

Growth in the number of healthcare facilities

Healthcare spending and government programs and initiatives

Migration from low-end equipment to high-end equipment

Growth in the diagnosed population and treatment population

Figure 67: GlobalData Epidemiology-Based Forecasting Model

Source: GlobalData




Page 1012

Capital Equipment-Based Forecasting Model

18.1.5 Company Share Analysis

Company shares are calculated by analyzing a company‘s sales in a particular market. In the case of public

companies, annual reports and regulatory filings, investor presentations, earnings call transcripts and broker reports

are used to determine a company‘s revenue in a particular market and in a particular geography.

In the case of the private companies, company share data is gathered mostly from primary interviews and secondary

sources. Company share analysis is based on primary interviews with:

Supply side (manufacturers)

Figure 68: GlobalData Capital Equipment-Based Forecasting Model

Source: GlobalData




Page 1013

Procurement side

Distributors

Hospital purchasing groups

Demand side (surgeons/specialists)

The benefits of this approach are:

High number of respondents to validate and from which to derive accurate company shares

Broad view from the supply, demand, and procurement side

Prevents biased opinions being reproduced

Demand-side interviews with key opinion leaders help to understand their preferences for the devices of

specific companies, strengthening company share estimates

Primary Interviews by Participant Type

Figure 69: Primary Interviews by Participant Type (%)

The final company share data is based on input from the supply side, the procurement side and the demand side, as

well as secondary sources.

50

25

25

Procurement side Supply side Demand side




Page 1014

18.1.6 Distribution Share Analysis

Distribution share information is gathered using a combination of secondary and primary research. It is supported by

primary interviews because the availability of secondary data is limited in most cases.

18.2 Expert Panel

GlobalData uses a panel of experts to cross-verify its databases and forecasts.

GlobalData‘s expert panel comprises marketing managers, product specialists, international sales managers from

medical device companies, academics from research universities, key opinion leaders from hospitals, consultants

from venture capital funds and distributors/suppliers of medical equipment and supplies.

Historic data and forecasts are relayed to GlobalData‘s expert panel for feedback and adjusted accordingly.

18.3 GlobalData Consulting

We hope that the data and analysis in this brief will help you to make informed and imaginative business decisions. If

you have further requirements, GlobalData‘s consulting team may be able to help you. GlobalData offers tailor-made

analytical and advisory services to drive your key strategic decisions.

18.5 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,

electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher,

GlobalData.

United States Diagnostic Imaging Market Outlook to 2020 · United States Diagnostic Imaging Market...

Documents

Transcript of United States Diagnostic Imaging Market Outlook to 2020 · United States Diagnostic Imaging Market...